<SEC-DOCUMENT>0001575705-22-000462.txt : 20220630
<SEC-HEADER>0001575705-22-000462.hdr.sgml : 20220630
<ACCEPTANCE-DATETIME>20220630112202
ACCESSION NUMBER:		0001575705-22-000462
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20220626
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220630
DATE AS OF CHANGE:		20220630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AgEagle Aerial Systems Inc.
		CENTRAL INDEX KEY:			0000008504
		STANDARD INDUSTRIAL CLASSIFICATION:	AIRCRAFT [3721]
		IRS NUMBER:				880422242
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36492
		FILM NUMBER:		221056941

	BUSINESS ADDRESS:	
		STREET 1:		8863 E 34TH STREET N
		CITY:			WICHITA
		STATE:			KS
		ZIP:			67226
		BUSINESS PHONE:		(620) 325-6363

	MAIL ADDRESS:	
		STREET 1:		8863 E 34TH STREET N
		CITY:			WICHITA
		STATE:			KS
		ZIP:			67226

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EnerJex Resources, Inc.
		DATE OF NAME CHANGE:	20060926

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MILLENNIUM PLASTICS CORP
		DATE OF NAME CHANGE:	20000525

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AURORA CORP
		DATE OF NAME CHANGE:	19990825
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>uavs_8k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:UAVS="http://ageagle.com/20220626">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_UAVS_ageagle.com_20220626 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20220626_20220626 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000008504 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:EntityCentralIndexKey">0000008504</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="uavs-20220626.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-06-26to2022-06-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000008504</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-26</xbrli:startDate>
        <xbrli:endDate>2022-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 14pt Times New Roman, Times, Serif"><b>UNITED
STATES<br />
SECURITIES AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif">&#160;<b>FORM
<span id="xdx_90F_edei--DocumentType_c20220626__20220626_zusIEirrHvG5"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Current Report</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b><br />
<b>Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Date of Report (Date of earliest event reported):
</b><span id="xdx_903_edei--DocumentPeriodEndDate_c20220626__20220626_zNLOyaMv3w7j"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 26, 2022</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 24pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="xdx_903_edei--EntityRegistrantName_c20220626__20220626_zslo39Ozy10h"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:EntityRegistrantName">AGEAGLE
AERIAL SYSTEMS INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 3pt">(Exact Name of Registrant as Specified
in Its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 35%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20220626__20220626_zxmOnQNrNsJh"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 30%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityFileNumber_c20220626__20220626_ztKfegcwHxbl"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:EntityFileNumber">001-36492</ix:nonNumeric></span></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 35%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20220626__20220626_zVCN63h5RlTa"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:EntityTaxIdentificationNumber">88-0422242</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction<br />
of Incorporation)</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20220626__20220626_zYnvCerdtjY1"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:EntityAddressAddressLine1">8833 E. 34th Street North</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityAddressCityOrTown_c20220626__20220626_zNzU9TO9wWbf"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:EntityAddressCityOrTown">Wichita</ix:nonNumeric></span> <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20220626__20220626_z8GHAQ99GGx8"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Kansas</ix:nonNumeric></span></b></span> <span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityAddressPostalZipCode_c20220626__20220626_zb9zLq66vA56"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:EntityAddressPostalZipCode">67226</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;(Address
of Registrant&#8217;s Principal Executive Office, Including Zip Code)</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 3pt"><b><span style="text-decoration: underline"><span id="xdx_90E_edei--CityAreaCode_c20220626__20220626_zgLcwAUnwvK1"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:CityAreaCode">(620)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20220626__20220626_zm6RkAuEn818"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:LocalPhoneNumber">325-6363</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 3pt">(Registrant&#8217;s Tele<span style="font-family: Times New Roman, Times, Serif">phone
Number, Including Area Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><span style="font-family: Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--WrittenCommunications_c20220626__20220626_zzd2C2zmKyV9"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 95%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--SolicitingMaterial_c20220626__20220626_zUvrBVaBPEy7"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20220626__20220626_z3YfWm9Xuoy6"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20220626__20220626_zq9UA22yo9V9"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Title
    of each class</span></td>
    <td style="border: black 1pt solid; padding-top: 1.5pt; padding-right: 1pt; padding-left: 1pt; text-align: justify; line-height: 107%; width: 20%"><span style="font: 10pt Times New Roman, Times, Serif">Trading
    Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--Security12bTitle_c20220626__20220626_z2YFXBfsZ2H1"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:Security12bTitle">Common
    Stock, par value $0.01 per share</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_c20220626__20220626_z3W4Pinpjmf1"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" name="dei:TradingSymbol">UAVS</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--SecurityExchangeName_c20220626__20220626_zheb4Ve4P0f1"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric></span> American</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Emerging growth
company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20220626__20220626_zdGPWCMCHIAl"><ix:nonNumeric contextRef="From2022-06-26to2022-06-26" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2022, AgEagle Aerial Systems Inc. (the &#8220;Company&#8221;) entered into a Securities Purchase Agreement (the &#8220;Agreement&#8221;)
with an institutional investor (the &#8220;Investor&#8221;) which is an existing shareholder of the Company. Pursuant to the terms of
the Agreement, the Board of Directors of the Company (the &#8220;Board&#8221;) authorized the sale of 10,000 shares of a newly designated
series of preferred stock, the Series F 5% Convertible Preferred Stock (the &#8220;Series F <span style="letter-spacing: -0.2pt">Convertible
</span>Preferred&#8221;) and warrants to purchase up to 16,129,032</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of the Company&#8217;s Common Stock an exercise price of $0.96 per share (the &#8220;Warrants&#8221;), for gross proceeds of approximately
$15.5</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million.
The Series F <span style="letter-spacing: -0.2pt">Convertible </span>Preferred will be convertible into 16,129,032 shares of the Company&#8217;s
common stock (the &#8220;Conversion Shares,&#8221; and together with the shares underlying the Warrants, the &#8220;Underlying Shares&#8221;)
at a conversion price of $0.62 per share. The Warrants are not exercisable for the first six months after issuance and have a three-year
term from the exercise date. Upon exercise of the Warrants in full by the Investor, the Company would receive additional gross proceeds
of approximately $10 million. The Investor has the right, subject to certain conditions, including shareholder approval, to purchase
up to an additional $25,000,000 of shares of Series F Convertible Preferred and warrants. That option will be available for a period
of 18 months after shareholder approval at a purchase price equal to the volume-weighted average pricings (&#8220;VWAPs&#8221;) of the
common stock for three trading days prior to the date the Investor gives notice to the Company that it will exercise the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
December 30</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2022, upon any issuance by the Company or any of its subsidiaries of Common Stock or Common Stock Equivalents for cash consideration,
Indebtedness or a combination of units thereof by the Company (a &#8220;Subsequent Financing&#8221;), the Investor shall have the right
to participate in up to 50% of the Subsequent Financing (the &#8220;Participating Maximum&#8221;) on the same terms, conditions and price
provided for in the Subsequent Financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
shareholder approval has been obtained, neither the Company nor any subsidiary shall engage in a Subsequent Financing which would cause
any adjustment of the conversion price or the exercise price to the extent the Investor would not be permitted, to convert its outstanding
shares of Series F <span style="letter-spacing: -0.2pt">Convertible</span> Preferred and exercise its Warrants in full, ignoring for
such purposes the other conversion or exercise limitations therein. Notwithstanding the foregoing, the Company and its subsidiaries are
not precluded from issuing securities in a Subsequent Financing that does not require shareholder approval, but such Subsequent Financings
are not excluded from the dilutive adjustment mechanisms of Series F <span style="letter-spacing: -0.2pt">Convertible</span> Preferred
or the Warrant to the extent such are otherwise applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Preferred Stock, the Warrant and the Underlying Shares were issued pursuant to a prospectus supplement dated June 26</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2022 and filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on the same date and the prospectus included
in the Company&#8217;s Registration Statement on Form S-3 (Registration No. 333-252801), which was initially
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">filed with the Commission on February
5,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021 and was declared effective on May 6, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lock-up
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2022, as a condition to the consummation of the Agreement, the Company entered into a Lock-up Agreement with the Investor and each officer
and director of the Company (collectively, the &#8220;Shareholders&#8221;), for the benefit of the Investor, with respect to the shares
beneficially owned the Shareholders. The restrictions on the disposition of the shares is for a period of 100 days from the date of the
closing of the Agreement (the &#8220;Restricted Period&#8221;), except for up to $250,000 worth of shares sold pursuant to a 10b5-1 trading
plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certificate
of Designation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2022, the Board, pursuant to its authority to designate blank check preferred stock, approved the designation of 35,000 shares
of Series F Convertible Preferred with a stated value of $1,000 per share. The Certificate of Designation was filed with the Secretary
of State of the State of Nevada on June 29, 2022. The Series F Convertible Preferred is convertible at a conversion price of $0.62
per share, and has liquidation rights senior to the Company&#8217;s Common Stock or any securities that is convertible into or exercisable
for the Common Stock. The Preferred Stock has no voting rights, except that the Company shall not undertake certain corporate actions
as set forth in the Certificate of Designation that would materially impact the holder of Series F Convertible Preferred (the &#8220;Holder&#8221;),
without consent of the Holder. The conversion price adjusts for stock splits and combinations, and is subject to anti-dilution protection
for subsequent equity issuances until such time as no shares of Series F Convertible Preferred is outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 45.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company has not obtained shareholder approval, the Company may not issue to the Holder upon conversion of the Series F Convertible
Preferred, a number of shares of Common Stock which, when aggregated with any shares of Common Stock then owned by the Holder, would
exceed 16,318,708</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of Common Stock (the &#8220;Issuable Maximum&#8221;). The Company shall endeavor to</span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain shareholder approval with respect to the issuance of
Underlying Shares in excess of 19.99% of the issued and outstanding shares of common stock as of June 30</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2022. The Certificate of Designation provides that the Company shall not convert the Series F Convertible Preferred, if after such conversion,
the beneficial ownership of the common stock by the Holder would in excess of 9.99% of the issued and outstanding shares of common stock
of the Company after giving effect to the issuance of the Underlying Shares (the &#8220;Beneficial Ownership Limitation&#8221;). The
Holder, upon prior notice, may decrease or increase the Beneficial Ownership Limitation, as long as it is not in excess of 9.99%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
  <tr style="vertical-align: top">
    <td style="padding: 0pt; width: 0px; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; padding: 0pt; width: 96px; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Exhibit
No.</b></span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Description
</b>&#160;</span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">3.1 &#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="ex3-1.htm">Certificate of Designation
of Series F 5% Convertible Preferred Stock, filed June 29, 2022</a></span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">4.1</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="ex4_1.htm">Common Stock Purchase
Warrant, dated June 30, 2022</a></span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">5.1</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #1F497D"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="ex5-1.htm">Opinion of Sherman &amp; Howard L.L.C.</a></span></p></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">10.1</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="ex10-1.htm">Securities Purchase
Agreement, dated June 26, 2022</a></span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">10.2</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="ex10_2.htm">Lock-up Agreement, dated
June 30, 2022</a></span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">99.1</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="ex99_1.htm">Press Release, dated
June 27, 2022</a></span></td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">99.2&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><a href="ex99_2.htm">Press Release, dated June 30, 2022&#160;</a></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 4.5pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 4.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
June 30</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2022&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="2" style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGEAGLE AERIAL SYSTEMS INC.</b></span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; width: 50%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; width: 5%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; width: 45%; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">By: </span></td>
<td style="border-bottom: black 1pt solid; padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Nicole Fernandez-McGovern</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; white-space: nowrap; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Name: </span></td>
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Nicole Fernandez-McGovern</span></td></tr>
<tr style="vertical-align: top">
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
<td style="padding: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 221pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 221pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2WmwVJfAyqYgsQiS6XXKKJd2R2e3vkXrLViUaBobhnO8cIUKxppVukeG0qEqosetb5RAqvCCjOaN3FJttDv5WeNXWsTJufH9gQZ5Bz2RRLJUXRutDW2xyiJOZnM+SGGSaZykcdiIY9ILMRTdonFYtKNPAgalnjU7xe0qo1YsMde+x6ohsNRkfF8lJ/kAi4wT29FBP4puFsixEEI4TiDXTvR9q7tZRB8sWO99lJ/S/wRcWOUlH -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EXHIBIT
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AGEAGLE
AERIAL SYSTEMS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATE
OF DESIGNATION OF PREFERENCES, </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>RIGHTS
AND LIMITATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SERIES
F<FONT STYLE="text-transform: uppercase"> 5</FONT>% CONVERTIBLE PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PURSUANT
TO SECTION 78.1955 OF THE </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">NEVADA
REVISED STATUTES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned, Barrett Mooney and Nicole Fernandez-McGovern, do hereby certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.
They are the President and Secretary, respectively, of AgEagle Aerial Sysems, Inc., a Nevada corporation (the &ldquo;<U>Corporation</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.
The Corporation is authorized to issue 25,000,000 shares of preferred stock, none of which have been issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.
The following resolutions were duly adopted by the board of directors of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
the articles of incorporation of the Corporation provides for a class of its authorized stock known as preferred stock, consisting
of 25,000,000 shares, $0.001 par value per share, issuable from time to time in one or more series;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms
of redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting
any series and the designation thereof, of any of them; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions
and other matters relating to a series of the preferred stock, which shall consist of, except as otherwise set forth in the Securities
Purchase Agreement, up to 35,000 shares of the preferred stock which the Corporation has the authority to issue, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for
cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions
and other matters relating to such series of preferred stock as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TERMS
OF PREFERRED STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
1</U>. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial Unicode MS; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Bankruptcy
Event</U>&rdquo; means any of the following events: (a) the Corporation or any Significant Subsidiary (as such term is defined
in Rule 1-02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement,
adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the
Corporation or any Significant Subsidiary thereof, (b) there is commenced against the Corporation or any Significant Subsidiary
thereof any such case or proceeding that is not dismissed within 60 days after commencement, (c) the Corporation or any Significant
Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding
is entered, (d) the Corporation or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for
it or any substantial part of its property that is not discharged or stayed within 60 calendar days after such appointment, (e)
the Corporation or any Significant Subsidiary thereof makes a general assignment for the benefit of creditors, (f) the Corporation
or any Significant Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring
of its debts, or (g) the Corporation or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates
its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of
effecting any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Base
Conversion Price</U>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning set forth in Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Buy-In</U>&rdquo;
shall have the meaning set forth in Section 6(c)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Change
of Control Transaction</U>&rdquo; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof
by an individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act)
of effective control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise)
of in excess of 33% of the voting securities of the Corporation (other than by means of conversion or exercise of Preferred Stock
and the Securities issued together with the Preferred Stock), (b) the Corporation merges into or consolidates with any other Person,
or any Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders
of the Corporation immediately prior to such transaction own less than 66% of the aggregate voting power of the Corporation or
the successor entity of such transaction, (c) the Corporation sells or transfers all or substantially all of its (and all of its
Subsidiaries, taken as a whole) assets to another Person and the stockholders of the Corporation immediately prior to such transaction
own less than 66% of the aggregate voting power of the acquiring entity immediately after the transaction, (d) a replacement at
one time or within a one year period of more than one-half of the members of the Board of Directors which is not approved by a
majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who
are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority
of the members of the Board of Directors who are members on the Original Issue Date), or (e) the execution by the Corporation
of an agreement to which the Corporation is a party or by which it is bound, providing for any of the events set forth in clauses
(a) through (d) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto and all conditions precedent to (i) each Holder&rsquo;s obligations to pay the Subscription Amount and (ii) the
Corporation&rsquo;s obligations to deliver the Securities have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Common
Stock</U>&rdquo; means the Corporation&rsquo;s common stock, par value $0.001 per share, and stock of any other class of securities
into which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof
to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other
instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to
receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Conversion
Amount</U>&rdquo; means the sum of the Stated Value at issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Conversion
Date</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning set forth in Section 6(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in
accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Dilutive
Issuance</U>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Dilutive
Issuance Notice</U>&rdquo; shall have the meaning set forth in Section 7(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Dividend
Payment Date</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Equity
Conditions</U>&rdquo; means, during the period in question, <FONT STYLE="color: black">(a) the Corporation shall have duly honored
all conversions scheduled to occur or occurring by virtue of one or more Notices of Conversion of the applicable Holder on or
prior to the dates so requested or required, if any, (b) the Corporation shall have paid all liquidated damages and other amounts
owing to the applicable Holder in respect of the Preferred Stock, </FONT>(c)(i) there is an effective Conversion Shares Registration
Statement pursuant to which the Holders are permitted to utilize the prospectus thereunder to resell all of the shares of Common
Stock issuable pursuant to the Transaction Documents (and the Corporation believes, in good faith, that such effectiveness will
continue uninterrupted for the foreseeable future) or (ii) all of the Conversion Shares issuable pursuant to the Transaction Documents
may be resold pursuant to Rule 144 without volume or manner-of-sale restrictions or current public information requirements as
determined by the counsel to the Corporation as set forth in a written opinion letter to such effect, addressed and acceptable
to the Transfer Agent and the affected Holders, (d) the Common Stock is trading on a Trading Market and all of the shares issuable
pursuant to the Transaction Documents are listed or quoted for trading on such Trading Market (and the Corporation believes, in
good faith, that trading of the Common Stock on a Trading Market will continue uninterrupted for the foreseeable future), (e)
there is a sufficient number of authorized, but unissued and otherwise unreserved, shares of Common Stock for the issuance of
all of the shares then issuable pursuant to the Transaction Documents, (f) there is no existing Triggering Event and no existing
event which, with the passage of time or the giving of notice, would constitute a Triggering Event, (g) the issuance of the shares
in question [(or, in the case of a redemption, the shares issuable upon conversion in full of the redemption amount) to the applicable
Holder would not violate the limitations set forth in Section 6(d) and Section 6(e) herein, <FONT STYLE="color: black">(h) there
has been no public announcement of a pending or proposed Fundamental Transaction or Change of Control Transaction that has not
been consummated, (i) the applicable Holder is not in possession of any information provided by the Corporation,</FONT> any of
its Subsidiaries, or any of their officers, directors, employees, agents or Affiliates,<FONT STYLE="color: black"> that constitutes,
or may constitute, material non-public information, and (j) for each Trading Day in a period of 20 consecutive Trading Days prior
to the applicable date in question, the daily trading volume for the Common Stock on the principal Trading Market exceeds $1,000,000.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Corporation
pursuant to any stock or option plan duly adopted by a majority of the non-employee members of the Board of Directors of the Corporation
or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon the exercise
or exchange of or conversion of any securities issued pursuant to the Purchase Agreement and/or other securities exercisable or
exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of the Purchase Agreement, provided
that such securities have not been amended since the date of the Purchase Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of any such securities or to extend the term of such securities,
and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Corporation, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith during the
prohibition period in Section 4.13 of the Purchase Agreement, and provided that any such issuance shall only be to a Person (or
to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in
a business synergistic with the business of the Corporation and shall provide to the Corporation additional benefits in addition
to the investment of funds, but shall not include a transaction in which the Corporation is issuing securities primarily for the
purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Holder</U>&rdquo;
shall have the meaning given such term in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Indebtedness</U>&rdquo;
means (a) any liabilities for borrowed money or amounts owed in excess of $250,000 (other than trade accounts payable incurred
in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Corporation&rsquo;s balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course
of business, and (c) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized
in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Issuable
Maximum</U>&rdquo; shall have the meaning set forth in Section 6(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Junior
Securities</U>&rdquo; means the Common Stock and all other Common Stock Equivalents of the Corporation other than those securities
which are explicitly senior or <U>pari</U> <U>passu</U> to the Preferred Stock in dividend rights or liquidation preference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Liquidation</U>&rdquo;
shall have the meaning set forth in Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>New
York Courts</U>&rdquo; shall have the meaning set forth in Section 11(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Notice
of Conversion</U>&rdquo; shall have the meaning set forth in Section 6(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers
of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such
Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Permitted
Indebtedness</U>&rdquo; means (a) the Indebtedness existing on the Original Issue Date and set forth on <U>Schedule 3.1(aa)</U>
attached to the Purchase Agreement and (b) lease obligations and purchase money indebtedness of up to $1,000,000, in the aggregate,
incurred in connection with the acquisition of capital assets and lease obligations with respect to newly acquired or leased assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Permitted
Lien</U>&rdquo; means the individual and collective reference to the following: (a) Liens for taxes, assessments and other governmental
charges or levies not yet due or Liens for taxes, assessments and other governmental charges or levies being contested in good
faith and by appropriate proceedings for which adequate reserves (in the good faith judgment of the management of the Corporation)
have been established in accordance with GAAP, (b) Liens imposed by law which were incurred in the ordinary course of the Corporation&rsquo;s
business, such as carriers&rsquo;, warehousemen&rsquo;s and mechanics&rsquo; Liens, statutory landlords&rsquo; Liens, and other
similar Liens arising in the ordinary course of the Corporation&rsquo;s business, and which (x) do not individually or in the
aggregate materially detract from the value of such property or assets or materially impair the use thereof in the operation of
the business of the Corporation and its consolidated Subsidiaries or (y) are being contested in good faith by appropriate proceedings,
which proceedings have the effect of preventing for the foreseeable future the forfeiture or sale of the property or asset subject
to such Lien, (c) Liens incurred in connection with Permitted Indebtedness under clause (a) thereunder, and (d) Liens incurred
in connection with Permitted Indebtedness under clause (b) thereunder, provided that such Liens are not secured by assets of the
Corporation or its Subsidiaries other than the assets so acquired or leased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Preferred
Stock</U>&rdquo; shall have the meaning set forth in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Securities Purchase Agreement, dated as of the Original Issue Date, among the Corporation and the
original Holders, as amended, modified or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Formm S-3 registering the sale of the Preferred Stock, Warrant
and Warrant Shares to the original Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Securities</U>&rdquo;
means the Preferred Stock, the Warrants, the Warrant Shares and the Underlying Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Stated
Value</U>&rdquo; shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the NYSE American (or any
successor entity) from the shareholders of the Corporation with respect to the transactions contemplated by the Transaction Documents,
including the issuance of all of the Underlying Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Subscription
Amount</U>&rdquo; shall mean, as to each Holder, the aggregate amount to be paid for the Preferred Stock purchased pursuant to
the Purchase Agreement as specified below such Holder&rsquo;s name on the signature page of the Purchase Agreement and next to
the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Corporation as set forth on <U>Schedule 3.1(a)</U> of the Purchase Agreement and shall, where applicable,
also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section 7(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Certificate of Designation, the Purchase Agreement, the Warrants, the Lock-Up Agreement, all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated
pursuant to the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Transfer
Agent</U>&rdquo; means EQ by Equiniti, the current transfer agent of the Corporation and any successor transfer agent of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; <FONT STYLE="color: black">shall have the meaning ascribed to such term in Section 4.13(b) of the
Purchase Agreement.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX
as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common
Stock are then reported in the &ldquo;Pink Sheets&rdquo; published by OTC Markets, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Corporation, the
fees and expenses of which shall be paid by the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Holder at the Closing in accordance with Section 2.2(a)
of the Purchase Agreement, which Warrants shall be exercisable six months after the Original Issue Date and have a term of exercise
equal to three years from their Initial Exercise Date, in the form of <U>Exhibit&nbsp;C</U> attached to the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
2</U>. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Designation, Amount and Par Value</U>. The series of preferred stock shall be designated as its Series F 5% Convertible
Preferred Stock (the &ldquo;<U>Preferred Stock</U>&rdquo;) and the number of shares so designated shall be up to 35,000 (which
shall not be subject to increase without the written consent of the holders of a majority of the then outstanding shares of the
Preferred Stock (each, a &ldquo;<U>Holder</U>&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;)). Each share of Preferred
Stock shall have a par value of $0.001 per share and a stated value equal to $1,000.00, subject to increase set forth in Section
3 below (the &ldquo;<U>Stated Value</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
3</U>. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Dividends</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Dividends
in Cash</U>. Holders shall be entitled to receive, and the Corporation shall pay, cumulative dividends at the rate per share (as
a percentage of the Stated Value per share) of 5% per annum)<B>,</B> payable quarterly on January 1, April 1, July 1 and October
1, beginning on the first Conversion Date and on each subsequent Conversion Date (with respect only to Preferred Stock being converted)
(each such date, a &ldquo;<U>Dividend Payment Date</U>&rdquo;) (if any Dividend Payment Date is not a Trading Day, the applicable
payment shall be due on the next succeeding Trading Day) in cash out of funds legally available therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Dividend
Calculations</U>. Dividends on the Preferred Stock shall be calculated on the basis of a 360-day year, consisting of twelve 30
calendar day periods, and shall accrue daily commencing on the first Conversion Date, and shall be deemed to accrue from such
date whether or not earned or declared and whether or not there are profits, surplus or other funds of the Corporation legally
available for the payment of dividends. Dividends shall cease to accrue with respect to any Preferred Stock converted, provided
that, the Corporation actually delivers the Conversion Shares within the time period required by Section 6(c)(i) herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Late
Fees</U>. Any dividends, that are not paid within three Trading Days following a Dividend Payment Date shall continue to accrue
and shall entail a late fee, which must be paid in cash, at the rate of 12% per annum or the lesser rate permitted by applicable
law which shall accrue daily from the Dividend Payment Date through and including the date of actual payment in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Other
Securities</U>. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall
redeem, purchase or otherwise acquire directly or indirectly any Junior Securities. So long as any Preferred Stock shall remain
outstanding, neither the Corporation nor any Subsidiary thereof shall directly or indirectly pay or declare any dividend or make
any distribution upon (other than a dividend or distribution described in Section 6 or dividends due and paid in the ordinary
course on preferred stock of the Corporation at such times when the Corporation is in compliance with its payment and other obligations
hereunder), nor shall any distribution be made in respect of, any Junior Securities as long as any dividends due on the Preferred
Stock remain unpaid, nor shall any monies be set aside for or applied to the purchase or redemption (through a sinking fund or
otherwise) of any Junior Securities or shares <U>pari</U> <U>passu</U> with the Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
4</U>. &nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Voting Rights</U>. Except as otherwise provided herein or as otherwise required by law, the Preferred Stock shall
have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the
affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock, (a) alter or change adversely
the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) authorize
or create any class of stock ranking as to dividends, redemption or distribution of assets upon a Liquidation (as defined in Section
5) senior to, or otherwise <U>pari</U> <U>passu</U> with, the Preferred Stock, (c) amend its articles of incorporation or other
charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares
of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
5</U>. &nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary
(a &ldquo;<U>Liquidation</U>&rdquo;), the Holders shall be entitled to receive out of the assets, whether capital or surplus,
of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated
damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution
or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to
pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders
in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.
The Corporation shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein,
to each Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
6</U>. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Conversions
at Option of Holder</U>. Each share of Preferred Stock shall be convertible, at any time and from time to time from and after
the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations
set forth in Section 6(d) and Section 6(e)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion
Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as <U>Annex
A</U> (a &ldquo;<U>Notice of Conversion</U>&rdquo;). Each Notice of Conversion shall specify the number of shares of Preferred
Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of
Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date
may not be prior to the date the applicable Holder delivers by .pdf via email such Notice of Conversion to the Corporation (such
date, the &ldquo;<U>Conversion Date</U>&rdquo;). If no Conversion Date is specified in a Notice of Conversion, the Conversion
Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice
of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice
of Conversion form be required.<I> </I>The calculations and entries set forth in the Notice of Conversion shall control in the
absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required
to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred
Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of
Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed
in accordance with the terms hereof shall be canceled and shall not be reissued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Conversion
Price</U>. The conversion price for the Preferred Stock shall equal <B>$0.62</B>, subject to adjustment herein (the &ldquo;<U>Conversion
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt; padding: 0; text-indent: 0"></TD><TD STYLE="width: 29pt; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)</FONT></TD><TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Mechanics
                                                                                                                            of
                                                                                                                            Conversion</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 90pt; text-align: justify; text-indent: -18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">i.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of Conversion Shares Upon Conversion</U>. Not later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &ldquo;<U>Share Delivery Date</U>&rdquo;),
the Corporation shall deliver, or cause to be delivered, to the converting Holder (A) the number of Conversion Shares being acquired
upon the conversion of the Preferred Stock which shall be free of restrictive legends and trading restrictions (other than those
which may then be required by the Purchase Agreement), and (B) shall deliver by wire transfer of immediately available funds the
amount of accrued and unpaid dividends. The Corporation shall deliver the Conversion Shares required to be delivered by the Corporation
under this Section 6 electronically through the Depository Trust Company or another established clearing corporation performing
similar functions. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Corporation&rsquo;s primary Trading Market with respect to the Common Stock as in effect on
the date of delivery of the Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Failure
to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or
as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the
Corporation at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation
shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall
promptly return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Obligation
Absolute; Partial Liquidated Damages</U>. The Corporation&rsquo;s obligation to issue and deliver the Conversion Shares upon conversion
of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction
by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against
any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach
or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation
of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation
of the Corporation to such Holder in connection with the issuance of such Conversion Shares; <U>provided</U>, <U>however</U>,
that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such
Holder. In the event a Holder shall elect to convert any or all of the Stated Value of its Preferred Stock, the Corporation may
not refuse conversion based on any claim that such Holder or any one associated or affiliated with such Holder has been engaged
in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining
and/or enjoining conversion of all or part of the Preferred Stock of such Holder shall have been sought and obtained, and the
Corporation posts a surety bond for the benefit of such Holder in the amount of 150% of the Stated Value of Preferred Stock which
is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying
dispute and the proceeds of which shall be payable to such Holder to the extent it obtains judgment. In the absence of such injunction,
the Corporation shall issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion. If the Corporation
fails to deliver to a Holder such Conversion Shares pursuant to Section 6(c)(i) by the Share Delivery Date applicable to such
conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $5,000 of
Stated Value of Preferred Stock being converted, $50 per Trading Day (increasing to $100 per Trading Day on the third Trading
Day and increasing to $200 per Trading Day on the sixth Trading Day after the Share Delivery Date) for each Trading Day after
the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. Nothing herein shall limit
a Holder&rsquo;s right to pursue actual damages or declare a Triggering Event pursuant to Section 10 hereof for the Corporation&rsquo;s
failure to deliver Conversion Shares within the period specified herein and such Holder shall have the right to pursue all remedies
available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive
relief. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section
hereof or under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">iv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Compensation
for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</U>. In addition to any other rights available to the
Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery
Date pursuant to Section 6(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase
(in an open market transaction or otherwise), or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock
to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the
conversion relating to such Share Delivery Date (a &ldquo;<U>Buy-In</U>&rdquo;), then the Corporation shall (A) pay in cash to
such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder&rsquo;s
total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the
aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by
(2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage
commissions) and (B) at the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the
number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver
to such Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its
delivery requirements under Section 6(c)(i). For example, if a Holder purchases shares of Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred Stock with respect to which
the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was
a total of $10,000 under clause (A) of the immediately preceding sentence, the Corporation shall be required to pay such Holder
$1,000. The Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the
Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver the Conversion Shares upon
conversion of the shares of Preferred Stock as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">v.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Reservation
of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available out of
its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock and
payment of dividends on the Preferred Stock, each as herein provided, free from preemptive rights or any other actual contingent
purchase rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate
number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable
(taking into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Preferred
Stock and payment of dividends hereunder. The Corporation covenants that all shares of Common Stock that shall be so issuable
shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable and, if the Conversion Shares Registration
Statement is then effective under the Securities Act, shall be registered for public resale in accordance with such Conversion
Shares Registration Statement (subject to such Holder&rsquo;s compliance with its obligations under the Registration Rights Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">vi.&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fractional
Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred
Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation
shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Conversion Price or round up to the next whole share. Notwithstanding anything to the contrary contained herein, but consistent
with the provisions of this subsection with respect to fractional Conversion Shares, nothing shall prevent any Holder from converting
fractional shares of Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Transfer
Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge to
any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion
Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved
in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares
of Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person
or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established
to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required
for same-day processing of any Notice of Conversion and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Beneficial
Ownership Limitation</U>.<I> </I>The Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not
have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth
on the applicable Notice of Conversion, such Holder (together with such Holder&rsquo;s Affiliates, and any Persons acting as a
group together with such Holder or any of such Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;))
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by such Holder and its Affiliates and Attribution Parties shall include
the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination
is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining,
unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates or Attribution Parties
and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to
a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred
Stock or the Warrants) beneficially owned by such Holder or any of its Affiliates or Attribution Parties. Except as set forth
in the preceding sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance with Section
13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in
this Section 6(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned
by such Holder together with any Affiliates and Attribution Parties) and of how many shares of Preferred Stock are convertible
shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&rsquo;s
determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder
together with any Affiliates and Attribution Parties) and how many shares of the Preferred Stock are convertible, in each case
subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, each Holder will be deemed to represent
to the Corporation each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions
set forth in this paragraph and the Corporation shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 6(d), in determining the
number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as stated
in the most recent of the following:</FONT>&nbsp;(i) the Corporation&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more recent written notice
by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">Upon the written or oral
request of a Holder, the Corporation shall within one Trading Day confirm orally and in writing to such Holder the number of shares
of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock held by the applicable Holder. A
Holder, upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions of this Section
6(d) applicable to its Preferred Stock provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion
of this Preferred Stock held by the Holder and the provisions of this Section 6(d) shall continue to apply. Any such increase
in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the
Corporation and shall only apply to such Holder and no other Holder. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 6(d) to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
Limitations</U>. Notwithstanding anything herein to the contrary, if the Corporation has not obtained Shareholder Approval, then the
Corporation may not issue, upon conversion of the Preferred Stock, a number of shares of Common Stock which, when aggregated with any
shares of Common Stock currently owned by a Holder, issued on or after the Original Issue Date and prior to such Conversion Date (i)
in connection with any conversion of Preferred Stock issued pursuant to the Purchase Agreement, and (ii) in connection with the exercise
of any Warrants issued pursuant to the Purchase Agreement, would exceed 16,318,708 shares of Common Stock (subject to adjustment
for forward and reverse stock splits, recapitalizations and the like) (such number of shares, the &ldquo;<U>Issuable Maximum</U>&rdquo;).
Each Holder shall be entitled to a portion of the Issuable Maximum equal to the quotient obtained by dividing (x) the original Stated
Value of such Holder&rsquo;s Preferred Stock by (y) the aggregate Stated Value of all Preferred Stock issued on the Original Issue Date
to all Holders. In addition, each Holder may allocate its pro-rata portion of the Issuable Maximum among Preferred Stock and Warrants
held by it in its sole discretion. Such portion shall be adjusted upward ratably in the event a Holder no longer holds any Preferred
Stock or Warrants and the amount of shares issued to such Holder pursuant to such Holder&rsquo;s Preferred Stock and Warrants was less
than such Holder&rsquo;s pro-rata share of the Issuable Maximum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
7</U>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9;<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Stock
Dividends and Stock Splits</U>. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a stock dividend
or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common
Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon
conversion of, or payment of a dividend on, this Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller
number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock
of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of
shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which
the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant
to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled to
receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Subsequent
Equity Sales</U>. If, at any time while this Preferred Stock is outstanding, the Corporation or any Subsidiary, as applicable
sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces
any sale, grant or any option to purchase or other disposition), any Common Stock or Common Stock Equivalents entitling any Person
to acquire shares of Common Stock at an effective price per share that is lower than the then Conversion Price (such lower price,
the &ldquo;<U>Base Conversion Price</U>&rdquo; and such issuances, collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (if
the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price
adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights
per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price
per share that is lower than the Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion
Price on such date of the Dilutive Issuance), then simultaneously with the consummation (or, if earlier, the announcement) of
each Dilutive Issuance the Conversion Price shall be reduced to equal the Base Conversion Price. <FONT STYLE="color: black">Notwithstanding
the foregoing, no adjustment will be made under this Section 7(b) in respect of an Exempt Issuance</FONT>. If the Corporation
enters into a Variable Rate Transaction, despite the prohibition set forth in the Purchase Agreement, the Corporation shall be
deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible conversion price at which such securities
may be converted or exercised. The Corporation shall notify the Holders in writing, no later than the Trading Day following the
issuance of any Common Stock or Common Stock Equivalents subject to this Section 7(b), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive
Issuance Notice</U>&rdquo;). For purposes of clarification, whether or not the Corporation provides a Dilutive Issuance Notice
pursuant to this Section 7(b), upon the occurrence of any Dilutive Issuance, the Holders are entitled to receive a number of Conversion
Shares based upon the Base Conversion Price on or after the date of such Dilutive Issuance, regardless of whether a Holder accurately
refers to the Base Conversion Price in the Notice of Conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Subsequent
Rights Offerings</U>. <FONT STYLE="color: black">In addition to any adjustments pursuant to Section 7(a) above, if at any time
the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then
the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which
the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion
of such Holder&rsquo;s Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the
Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such
Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder&rsquo;s right to
participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock
as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder
until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Pro
Rata Distributions</U>. During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of
capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder
shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the
Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Preferred Stock (without regard
to any limitations on conversion hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, to
the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the
Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Fundamental
Transaction</U>. If, at any time while this Preferred Stock is outstanding, (i) the Corporation, directly or indirectly, in one
or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation
(and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any,
direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or
property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Corporation, directly or
indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other
securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related transactions consummates
a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares
of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent conversion of this Preferred Stock, the Holder
shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior
to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 6(d) and Section 6(e) on the conversion
of this Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation,
if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Preferred Stock
is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6(d) and Section
6(e) on the conversion of this Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one share of Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate
Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion
of this Preferred Stock following such Fundamental Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To the extent necessary to effectuate the foregoing provisions,
any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation
with the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing
the Holders&rsquo; right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any successor
entity in a Fundamental Transaction in which the Corporation is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to
assume in writing all of the obligations of the Corporation under this Certificate of Designation and the other Transaction Documents
(as defined in the Purchase Agreement) in accordance with the provisions of this Section 7(e) pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such
Fundamental Transaction and shall, at the option of the holder of this Preferred Stock, deliver to the Holder in exchange for
this Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Preferred Stock
(without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction, and with
a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such
number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be
substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation
and the other Transaction Documents referring to the &ldquo;Corporation&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Certificate
of Designation and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Corporation
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Calculations</U>.
All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.
For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Notice
to the Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Adjustment
to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation
shall promptly deliver to each Holder by email a notice setting forth the Conversion Price after such adjustment and setting forth
a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Notice
to Allow Conversion by Holder</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock,
(C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation
is a party, any sale or transfer of all or substantially all of the assets of the Corporation (and all of its Subsidiaries, taken
as a whole), or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or
(E) <FONT STYLE="color: black">the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained
for the purpose of conversion of this Preferred Stock, and shall cause to be delivered by email to each Holder at its last email
address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating </FONT>(x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which
the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to
be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled
to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery
thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any
notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries,
the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder
shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 20-day period commencing
on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly
set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
8</U>. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<FONT STYLE="color: black"><U>Negative Covenants</U>. As long as any shares of Preferred Stock are outstanding, unless
the holders of at least 67% in Stated Value of the then outstanding shares of Preferred Stock shall have otherwise given prior
written consent, the Corporation shall not, and shall not permit any of the Subsidiaries to, directly or indirectly:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;other
than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any indebtedness for borrowed money
of any kind, including but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter
acquired or any interest therein or any income or profits therefrom;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other
than Permitted Liens, enter into, create, incur, assume or suffer to exist any Liens of any kind, on or with respect to any of
its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;amend
its charter documents, including, without limitation, its certificate of incorporation and bylaws, in any manner that materially
and adversely affects any rights of the Holder, except for any amendment to the Corporation&rsquo;s bylaws to lower its quorum
requirement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;repay,
repurchase or offer to repay, repurchase or otherwise acquire more than a <U>de</U> <U>minimis</U> number of shares of its Common
Stock, Common Stock Equivalents or Junior Securities, other than as to (i) the Conversion Shares or Warrant Shares as permitted
or required under the Transaction Documents and (ii) repurchases of Common Stock or Common Stock Equivalents of departing officers
and directors of the Corporation, provided that such repurchases shall not exceed an aggregate of $100,000 for all officers and
directors for so long as the Preferred Stock is outstanding;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">e)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pay
cash dividends or distributions on Junior Securities of the Corporation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">f)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into any transaction with any Affiliate of the Corporation which would be required to be disclosed in any public filing with the
Commission, unless such transaction is made on an arm&rsquo;s-length basis and expressly approved by a majority of the disinterested
directors of the Corporation (even if less than a quorum otherwise required for board approval); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">g)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Section
10</U>.&nbsp;&nbsp;&nbsp;&nbsp; &#9;<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation,
any Notice of Conversion, shall be in writing and delivered personally, by e-mail attachment, or sent by a nationally recognized
overnight courier service, addressed to the Corporation, at the address set forth above Attention: Nicole Fernandez-McGovern,
e-mail address Nicole.Fernandez@ageagle.com, or such other e-mail address or address as the Corporation may specify for such purposes
by notice to the Holders delivered in accordance with this Section 11. Any and all notices or other communications or deliveries
to be provided by the Corporation hereunder shall be in writing and delivered personally, by e-mail attachment, or sent by a nationally
recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the
books of the Corporation, or if no such e-mail address or address appears on the books of the Corporation, at the principal place
of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication or deliveries hereunder
shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered
via e-mail attachment at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii)
the next Trading Day after the date of transmission, if such notice or communication is delivered via e-mail attachment at the
e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any
Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service, or (iv) upon actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absolute
Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the
obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest,
as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lost
or Mutilated Preferred Stock Certificate</U>. If a Holder&rsquo;s Preferred Stock certificate shall be mutilated, lost, stolen
or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated
certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of
Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction
of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation
shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada without regard to
the principles of conflict of laws thereof. All legal proceedings concerning the interpretation, enforcement and defense of the
transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates,
directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the City
of New York, Borough of Manhattan (the &ldquo;<U>New York Courts</U>&rdquo;). The Corporation and each Holder hereby irrevocably
submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for
such proceeding. The Corporation and each Holder hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. The Corporation
and each Holder hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury
in any legal proceeding arising out of or relating to this Certificate of Designation or the transactions contemplated hereby.
If the Corporation or any Holder shall commence an action or proceeding to enforce any provisions of this Certificate of Designation,
then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&rsquo; fees and
other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Waiver</U>.
Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as
or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate
of Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to
any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or
any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of
Designation on any other occasion. Any waiver by the Corporation or a Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Severability</U>.
If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation
shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable
to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates
the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">g)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Next
Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Headings</U>.
The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall
not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Status
of Converted or Redeemed Preferred Stock</U>. Shares of Preferred Stock may only be issued pursuant to the Purchase Agreement.
If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall resume the status
of authorized but unissued shares of preferred stock and shall no longer be designated as Series F 5% Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">*********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">RESOLVED,
FURTHER, that the Chairman, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation
be and they hereby are authorized and directed to prepare and file this Certificate of Designation of Preferences, Rights and
Limitations in accordance with the foregoing resolution and the provisions of Nevada law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Certificate this 28th day of June, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%; font: 12pt/107% Calibri, Helvetica, Sans-Serif; padding: 0; text-indent: 0; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Barrett Mooney</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 7%">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 43%; font: 10pt/107% Times New Roman, Times, Serif; padding: 0; text-indent: 0">/s/
Nicole Fernandez-McGovern<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Barrett Mooney</FONT></TD>
<TD>&nbsp;</TD>
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nicole Fernandez-McGovern</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">President</FONT></TD>
<TD>&nbsp;</TD>
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Secretary</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ANNEX
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">NOTICE
OF CONVERSION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">(To
be Executed by the Registered Holder in order to Convert Shares of Preferred Stock)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
undersigned hereby elects to convert the number of shares of Series F 5% Convertible Preferred Stock indicated below into shares
of common stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of AgEagle Aerial Systems Inc., a Nevada
corporation (the &ldquo;<U>Corporation</U>&rdquo;), according to the conditions hereof, as of the date written below. If shares
of Common Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes
payable with respect thereto and is delivering herewith such certificates and opinions as may be required by the Corporation in
accordance with the Purchase Agreement. No fee will be charged to the Holders for any conversion, except for any such transfer
taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion
calculations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; width: 100%; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    to Effect Conversion: _____________________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock owned prior to Conversion: _______________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock to be Converted: ________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
    Value of shares of Preferred Stock to be Converted: ____________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Common Stock to be Issued: ___________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable
    Conversion Price:____________________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of shares of Preferred Stock subsequent to Conversion: ________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Arial Unicode MS; text-align: justify; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
                                            for Delivery: ______________________</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>or</U></FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
    Instructions:</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker
    no: _________</FONT></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    no: ___________</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[HOLDER]</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="line-height: 107%; width: 50%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="line-height: 107%; width: 5%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
<TD STYLE="line-height: 107%; width: 45%; padding: 0; text-indent: 0; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0">&nbsp;</TD>
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0">&nbsp;</TD>
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">27</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ex4_1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EXHIBIT 4.1&#9;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ageagle
aerial systems, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: 16,129,032&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Initial
Exercise Date: December 30, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
Date: June 30, 2022<FONT STYLE="text-transform: uppercase"><B>&#9;</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">THIS COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Alpha Capital Anstalt or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date that is six months after the Issue Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York
City time) on the three year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter,
to subscribe for and purchase from AgEagle Aerial Systems, Inc. a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to 16,129,032
shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><U>Section 1</U>.&#9;<U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated June 26, 2022, among the Company and the purchasers signatory thereto.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>.&#9;<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.96</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either
(y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common
Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="padding: 0pt; width: 0.25in; text-indent: 0pt"></TD><TD STYLE="padding: 0pt; width: 0.25in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after
delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period
after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share
Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent
that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="padding: 0pt; width: 0.25in; text-indent: 0pt"></TD><TD STYLE="padding: 0pt; width: 0.25in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD><TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Holder&rsquo;s
                                            Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and
                                            a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section
                                            2 or otherwise, to the extent that after giving effect to such issuance after exercise as
                                            set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
                                            Affiliates, and any other Persons acting as a group together with the Holder or any of the
                                            Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would
                                            beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For
                                            purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned
                                            by the Holder and its Affiliates and Attribution Parties shall include the number of shares
                                            of Common Stock issuable upon exercise of this Warrant with respect to which such determination
                                            is being made, but shall exclude the number of shares of Common Stock which would be issuable
                                            upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned
                                            by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
                                            of the unexercised or nonconverted portion of any other securities of the Company (including,
                                            without limitation, any other Common Stock Equivalents) subject to a limitation on conversion
                                            or exercise analogous to the limitation contained herein beneficially owned by the Holder
                                            or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,
                                            for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
                                            with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
                                            it being acknowledged by the Holder that the Company is not representing to the Holder that
                                            such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
                                            solely responsible for any schedules required to be filed in accordance therewith. To the
                                            extent that the limitation contained in this Section 2(e) applies, the determination of whether
                                            this Warrant is exercisable (in relation to other securities owned by the Holder together
                                            with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
                                            shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
                                            shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
                                            (in relation to other securities owned by the Holder together with any Affiliates and Attribution
                                            Parties) and of which portion of this Warrant is exercisable, in each case subject to the
                                            Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm
                                            the accuracy of such determination. In addition, a determination as to any group status as
                                            contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
                                            and the rules and regulations promulgated thereunder. For purposes of this Section 2(e),
                                            in determining the number of outstanding shares of Common Stock, a Holder may rely on the
                                            number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most
                                            recent periodic or annual report filed with the Commission, as the case may be, (B) a more
                                            recent public announcement by the Company or (C) a more recent written notice by the Company
                                            or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon
                                            the written or oral request of a Holder, the Company shall within one Trading Day confirm
                                            orally and in writing to the Holder the number of shares of Common Stock then outstanding.
                                            In any case, the number of outstanding shares of Common Stock shall be determined after giving
                                            effect to the conversion or exercise of securities of the Company, including this Warrant,
                                            by the Holder or its Affiliates or Attribution Parties since the date as of which such number
                                            of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
                                            shall be 9.99% of the number of shares of the Common Stock outstanding immediately after
                                            giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
                                            The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
                                            Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
                                            in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
                                            after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant
                                            held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase
                                            in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
                                            after such notice is delivered to the Company. The provisions of this paragraph shall be
                                            construed and implemented in a manner otherwise than in strict conformity with the terms
                                            of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
                                            or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
                                            make changes or supplements necessary or desirable to properly give effect to such limitation.
                                            The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
Limitations</U>. Notwithstanding anything herein to the contrary, if the Company has not obtained Shareholder Approval, then the Company
may not issue, upon exercise of this Warrant, a number of shares of Common Stock which, when aggregated with any shares of Common Stock
issued on or after the Issue Date and prior to such Exercise Date in connection with any exercise of this Warrant or conversion of Preferred
Stock issued pursuant to the Purchase Agreement would exceed 16,318,708 shares of Common Stock (subject to adjustment for forward
and reverse stock splits, recapitalizations and the like) (such number of shares, the &ldquo;<U>Issuable Maximum</U>&rdquo;). Each Holder
shall be entitled to a portion of the Issuable Maximum equal to the quotient obtained by dividing (x) the original Stated Value of such
Holder&rsquo;s Preferred Stock by (y) the aggregate Stated Value of all Preferred Stock issued on the Original Issue Date to all Holders.
In addition, each Holder may allocate its pro-rata portion of the Issuable Maximum among Preferred Stock and Warrants held by it in its
sole discretion. Such portion shall be adjusted upward ratably in the event a Holder no longer holds any Preferred Stock or Warrants
and the amount of shares issued to such Holder pursuant to such Holder&rsquo;s Preferred Stock and Warrants was less than such Holder&rsquo;s
pro-rata share of the Issuable Maximum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>.&#9;<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsequent
Equity Sales</U>. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell,
enter into an agreement to sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue
(or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents, at
an effective price per share less than the Exercise Price then in effect (such lower price, the &ldquo;<U>Base Share Price</U>&rdquo;
and such issuances collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (it being understood and agreed that if the holder of the
Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price,
such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective
price), then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall
be reduced and only reduced to equal the Base Share Price. Notwithstanding the foregoing, no adjustments shall be made, paid or issued
under this Section 3(b) in respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading
Day following the issuance or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating
therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice,
the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a Dilutive Issuance
Notice pursuant to this Section 3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant
Shares based upon the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise.
If the Company enters into a Variable Rate Transaction, the Company shall be deemed to have issued Common Stock or Common Stock Equivalents
at the lowest possible price, conversion price or exercise price at which such securities may be issued, converted or exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or
more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common
equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) or Section
2(f)) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company,
if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as
a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) or Section 2(f) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, other
than one in which a Successor Entity (as defined below) that is a publicly traded corporation whose stock is quoted or listed on a Trading
Market assumes this Warrant such that the Warrant shall be exercisable for the publicly traded Common Stock of such Successor Entity,
in the event of a Fundamental Transaction, not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board
of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration
(and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to
the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form
of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock
of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed
to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such
Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing
Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable Fundamental
Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Treasury rate for a period equal
to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date,
(B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined
utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated
Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price
per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction
and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable
contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading
Day of the Holder&rsquo;s request pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the date of
the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.
The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents
in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>.&#9;<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>.&#9;<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)<BR STYLE="clear: both">
</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGEAGLE
AERIAL SYSTEMS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Nicole Fernandez-McGovern</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
Nicole Fernandez-McGovern</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
Secretary</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:&#9;ageagle
aerial systems, inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;<B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 40%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 60%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Address:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Phone Number:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Email Address:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="width: 73%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________ ________,
_________</FONT></TD>
    <TD STYLE="width: 9%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD>____________________________________</TD>
    <TD></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD>____________________________________<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 9pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1 </B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30, 2022</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">AgEagle
Aerial Systems Inc.</FONT></P>

<P STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">8833
East 34<SUP>th</SUP> Street North</FONT></P>

<P STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">Wichita,
Kansas 67226</FONT></P>

<P STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal"><B><I>Re:</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal"><B><I>AgEagle
                                            Aerial Systems Inc./Registration Statement on Form S-3</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: small-caps 12pt/97% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We have acted as special
Nevada counsel to AgEagle Aerial Systems Inc., a Nevada corporation (the &ldquo;Company&rdquo;), in connection with the registration
and issuance by the Company of: (a) 10,000 shares of Series F 5% Convertible Preferred Stock (the &ldquo;Preferred Shares&rdquo;)
convertible into 16,129,032 shares (the &ldquo;Conversation Shares&rdquo;) of the Company&rsquo;s Common Stock, $0.001 par value per
share (&ldquo;Common Stock&rdquo;) and (b) 16,129,032 Common Stock Purchase Warrants (the &ldquo;Warrants&rdquo;) to purchase an equal
number shares of Common Stock (the &ldquo;Underlying Shares&rdquo;) at an exercise price of $0.96 per share.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Securities are being issued
by the Company pursuant to a Securities Purchase Agreement, dated as of June 26, 2022 (the &ldquo;Purchase Agreement&rdquo;) filed as
an exhibit to the Company&rsquo;s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
(the &ldquo;Current Report&rdquo;), as well as an effective registration statement (the &ldquo;Registration Statement&rdquo;) on Form
S-3 (File No. 333-252801), the statutory prospectus dated May 6, 2021, included in the Registration Statement (the &ldquo;Base
Prospectus&rdquo;), and the prospectus supplement dated June 26, 2022 (the &ldquo;Prospectus Supplement&rdquo;) to be filed
with the Commission pursuant to Rule 424(b)(5) promulgated under the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;).</P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of these opinions, we have examined the Purchase Agreement, the Registration Statement, and originals or copies, certified or
otherwise identified to our satisfaction, of corporate records of the Company, certificates, forms of agreements, resolutions of the
Board of Directors of the Company, and such other matters as relevant related to the issuance and the registration of the Shares under
the Securities Act as we have deemed necessary or appropriate as a basis for the opinions set forth herein.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In our examination, we have assumed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the legal capacity of all natural persons executing the documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the genuineness of all signatures on the documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the authenticity of all documents submitted to us as originals, and the conformity to original documents of all documents submitted to
us as copies;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
that the parties to such documents, other than the Company, had the power, corporate or other, to enter into and perform all obligations
thereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the due authorization by all requisite action, corporate or other, the execution and delivery by all parties of the documents, and the
validity and binding effect thereof on such parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The opinions expressed below are
subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium, and other similar laws of general application affecting
the rights and remedies of creditors and to general principals of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On the basis of the foregoing
and in reliance thereon, and subject to the assumptions, limitations, and qualifications set forth herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Shares have been duly authorized and when issued, delivered, and paid for in accordance with the terms of the Purchase Agreement,
will be validly issued, fully paid, and nonassessable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Warrants have been duly authorized and when issued, delivered, and paid for in accordance with the terms of the Purchase Agreement,
will be validly issued and binding obligations of the Company to issue the Underlying Shares; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Underlying Shares have been duly authorized and reserved for issuance, and when issued, delivered, and paid for in accordance with
the terms of the exercise of the Warrants, will be validly issued, fully paid, and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The opinions expressed herein
are limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We
disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed herein or any changes in applicable law
that may come to our attention subsequent to the date the Registration Statement is declared effective.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">While certain members of this
firm are admitted to practice in certain jurisdictions other than Nevada, in rendering the foregoing opinions we have not examined the
laws of any jurisdiction other than Nevada. Accordingly, the opinions we express herein are limited to matters involving the laws of
the State of Nevada, excluding securities laws of the State of Nevada (to which we express no opinion). We express no opinion regarding
the effect of the laws of any other jurisdiction or state, including any securities laws related to the issuance and sale of the Shares,
Warrants and Underlying Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
&#9;We hereby consent to the use of this opinion letter as Exhibit 5.1 to the Registration Statement and to the use of our name under
the caption &#8220;Legal Matters&#8221; in the Registration Statement and in the Prospectus forming a part thereof and any supplement
thereto. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required under
Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Sherman &amp; Howard L.L.C.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHERMAN
&amp; HOWARD L.L.C.</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#9;<B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">This Securities Purchase
Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of June 26, 2022, between AgEagle Aerial Systems Inc., a Nevada corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">WHEREAS, subject to the
terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as
defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of
which are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm">ARTICLE I.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have
the meanings given to such terms in the Certificate of Designation (as defined herein), and (b) the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to
be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of
any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks
in The City of New York generally open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Certificate
of Designation</U>&rdquo; means the Certificate of Designation to be filed prior to the Closing by the Company with the Secretary
of State of Nevada, in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii)
the Company&rsquo;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than
the second (2<SUP>nd</SUP>) Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Loeb &amp; Loeb, LLP, with offices located at 345 Park Avenue, New York, NY 10022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Conversion
Price</U>&rdquo; shall have the meaning ascribed to such term in the Certificate of Designation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Conversion
Shares</U>&rdquo; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in
accordance with the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time)
and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following
the date hereof, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time)
on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the
Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits
or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration
statement in connection therewith during the prohibition period in Section 4.12(a) herein (other than securities registered on
Form S-4 which are not being issued in connection with any financing in connection with such S-4 transaction), and, provided that
any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the
Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers
of the Company in the form of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Maximum
Rate</U>&rdquo; shall have the meaning ascribed to such term in Section 5.17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Preferred
Stock</U>&rdquo; means the up to 35,000 shares of the Company&rsquo;s Series F 5% Convertible Preferred Stock issued hereunder
having the rights, preferences and privileges set forth in the Certificate of Designation, in the form of <U>Exhibit A</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with
the Commission and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with the Commission file No. 333-252801 which registers the sale
of the Preferred Stock, Warrants and Underlying Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Required
Minimum</U>&rdquo; means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable
in the future pursuant to the Transaction Documents, including any Underlying Shares issuable upon exercise in full of all Warrants
or conversion in full of all shares of Preferred Stock, ignoring any conversion or exercise limits set forth therein, and that
any previously unconverted shares of Preferred Stock are held until the third anniversary of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Securities</U>&rdquo;
means the Preferred Stock, the Warrants, the Warrant Shares and the Underlying Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the NYSE American (or any
successor entity) from the shareholders of the Company with respect to the transactions contemplated by the Transaction Documents,
including the issuance of all of the Underlying Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall
not be deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Stated
Value</U>&rdquo; means $1,000 per share of Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Subscription
Amount</U>&rdquo; <FONT STYLE="color: black">means, as to each Purchaser, the aggregate amount to be paid for the Preferred Stock
and Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next
to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct
or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Certificate of Designation, the Warrants, [the Lock-Up Agreement, all exhibits and
schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Transfer Agent</U>&rdquo;
means EQ by Equiniti, the current transfer agent of the Company, with a mailing address of 3200 Cherry Creek South Drive, Suite 430,
Denver, Colorado 80209 and an email address of Cheryl.Kelly@equiniti.com, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Underlying
Shares</U>&rdquo; means the shares of Common Stock issued and issuable upon conversion or redemption of the Preferred Stock and
upon exercise of the Warrants and issued and issuable in lieu of the cash payment of dividends on the Preferred Stock in accordance
with the terms of the Certificate of Designation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; <FONT STYLE="color: black">shall have the meaning ascribed to such term in Section 4.13(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the
volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then
reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of
Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the
Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a)
hereof, which Warrants shall be exercisable six months after the Original Issue Date and have a term of exercise equal to three
years from their Initial Exercise Date, in the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm">ARTICLE II.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Closing</U>.
On the initial Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution
and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $10,000,000 of shares of Preferred Stock with an aggregate Stated Value for each Purchaser
equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser, and Warrants
as determined by pursuant to Section 2.2(a). The aggregate number of shares of Preferred Stock sold hereunder shall be up to 10,000.
Each Purchaser shall deliver to the Company via wire transfer, immediately available funds equal to its Subscription Amount, and
the Company shall deliver to each Purchaser its respective shares of Preferred Stock and Warrants, as determined pursuant to Section
2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon
satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic
transfer of the Closing documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(a)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On or prior
to the initial Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 100pt"></TD><TD STYLE="width: 36pt">(i)</TD><TD STYLE="text-align: justify">this Agreement duly executed by the Company;</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
                                                                                                                                                    <TR STYLE="vertical-align: top">
<TD STYLE="width: 100pt">&nbsp;</TD><TD STYLE="width: 36pt">(ii)</TD><TD STYLE="text-align: justify">a legal
opinion of Company Counsel, substantially in the form of <U>Exhibit C</U> attached hereto;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;(iii)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a certificate
evidencing a number of shares of Preferred Stock equal to such Purchaser&rsquo;s Subscription Amount divided by the Stated Value,
registered in the name of such Purchaser and evidence of the filing and acceptance of the Certificate of Designation from the Secretary
of State of Nevada;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;a Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s
Conversion Shares on the date hereof, with an exercise price equal to $0.96, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;the Company
shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;(vi)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;on the
date hereof, the duly executed Lock-Up Agreements; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;(vii)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Prospectus
and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;On or prior
to the initial Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 100pt"></TD><TD STYLE="width: 36pt">(i)</TD><TD STYLE="text-align: justify">this Agreement duly executed by such Purchaser; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 144pt; text-align: justify; text-indent: -36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 36pt">&nbsp;&nbsp;(ii)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such Purchaser&rsquo;s
Subscription Amount by wire transfer to the account specified in writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt; text-align: justify">(b)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On each Additional Closing Date (as hereinafter
defined), subject to the conditions to the Additional Closing, the Company shall deliver:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 100pt">(i)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A certificate evidencing a number of
shares of Preferred Stock equal to such Purchaser&rsquo;s Subscription Amount divided by the Stated Value, registered in the name
of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 108pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 100pt; text-align: justify">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;a Warrant registered in the name of
such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s Conversion Shares on
the Additional Closing Date, with an exercise price equal to $0.96, subject to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 108pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 100pt; text-align: justify">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;an Officers&rsquo; Certificate, executed
by the Chief Executive Officer and the Chief Financial Officer, certifying that the Company has performed all covenants to be performed
by it pursuant to the Transaction Documents, that all representations and warranties contained in Article 3 hereof remain true
and correct as of the date of the second Closing, and that no Event of Default (or event that with the giving of notice or the
passage of time could become an Event of Default) has occurred and is continuing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 108pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 100pt; text-indent: 0cm; text-align: justify">(c) On each Additional Closing Date,
each subscribing Purchaser shall deliver to the Company such Purchaser&rsquo;s Additional Subscription Amount by wire transfer
to the account specified in writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 108pt; text-indent: 0cm">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;The obligations
of the Company hereunder in connection with each Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(i)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the accuracy
in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific
date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties are
qualified by materiality, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;all obligations,
covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(iii)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the delivery
by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(b)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The respective
obligations of the Purchasers hereunder in connection with each Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;the accuracy
in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the applicable Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations
or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(ii)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all obligations,
covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;the delivery
by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there shall
have been no Material Adverse Effect with respect to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;as to each
Additional Closing, the Company shall have obtained Shareholder Approval;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 29pt">(vi)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from the
date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are
reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in
each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 72pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"><FONT STYLE="color: black">2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Additional
Closings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 9pt">i.</TD><TD STYLE="text-align: justify"><U>Purchasers&rsquo; Additional Investment</U>. During the period beginning on the initial Closing
Date and ending on the 18 month anniversary of the Company&rsquo;s receipt of Shareholder Approval, the Purchasers (pro rata by
initial Subscription Amounts) shall each, severally and not jointly, have the right to purchase additional Preferred Stock and
Warrants from the Company, in minimum aggregate Subscription Amount tranches of $2,000,000 each, up to a total aggregate additional
Stated Value of Preferred Stock equal to $25,000,000 (in addition to the initial $10,000,000 Stated Value of Preferred Stock) (each,
an &ldquo;Additional Closing&rdquo; and the date, an &ldquo;Additional Closing Date&rdquo; and the amount subscribed for, the &ldquo;Additional
Subscription Amount&rdquo;). The Purchaser(s) shall give the Company not less than five Trading Days&rsquo; written notice of its/their
intention to purchase additional Preferred Stock and Warrants. The additional Preferred Stock and Warrants shall be identical to
the initial Preferred Stock and Warrants, except the Original Issue Date of the Preferred Stock and the Initial Exercise Date and
Termination Date of the Warrants shall be from the applicable subsequent Closing Date, and the purchase price per share of Preferred
Stock shall be adjusted such that the Conversion Price shall equate to the average of the VWAPs for the three Trading Days prior
to the date on which the Purchaser gives notice to the Company of an Additional Closing, and the Warrant Exercise Price shall also
be the average of the VWAPs for the three Trading Days prior to the date on which the Purchaser gives notice to the Company of
an Additional Closing. As a condition to the Purchasers&rsquo; expectation to purchase each subsequent tranche of Preferred Stock
and Warrants, (i) the Equity Conditions (as defined in the Certificate of Designation) shall have been met (or waived, in whole
or in part, by the subscribing Purchaser) and the Closing Price shall not be less than the Conversion Price; (ii) any required
Shareholder Approval shall have been obtained; and (iii) the Company shall not be or become in default of any other Indebtedness.
Each subsequent Closing shall otherwise be in accordance with Sections 2.2 and 2.3.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 108pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm">ARTICLE III.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Representations
and Warranties of the Company</U>. </FONT>Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be
deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in
the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to
each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the
issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free
of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references
to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(b)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries (except for EnerJex Kansas, which is inactive) is an entity duly
incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation
or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as
currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries,
other than EnerJex Kansas, is duly qualified to conduct business and is in good standing as a foreign corporation or other entity
in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to
result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material
adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and
the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse
Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to
revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith
or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the
terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>No Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party,
the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and
will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other
instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary
is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required
Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities
laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case
of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)
the filings required pursuant to Section 4.6 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement,
(iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing
of the Underlying Shares for trading thereon in the time and manner required thereby, (iv) such filings as are required to be made
under applicable state securities laws and (v) Shareholder Approval (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company. The Underlying Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized
capital stock a number of shares of Common Stock for issuance of the Underlying Shares at least equal to the Required Minimum on
the date hereof. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities
Act, which became effective on&nbsp;May 6, 2021 (the &ldquo;<U>Effective Date</U>&rdquo;), including the Prospectus, and such amendments
and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under
the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or
preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted
or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and regulations of
the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">At the time the Registration Statement and
any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and
any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not
and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time
the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material
respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The
Company is eligible to use Form S-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate
market value of securities being sold pursuant to this offering and during the twelve (12) months prior to this offering, as set
forth in General Instruction I.B.6 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U>
shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the
date hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act,
other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares
of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or
exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the
transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and as set
forth on <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for,
or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary,
or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue
additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the
Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other
than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that
adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the
Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights
or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of
Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements
or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>SEC Reports;
Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed
by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis
or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such
extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule
144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects
with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the
time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in
such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required
by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as
of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>: (i) there has been no event, occurrence or development that
has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent
with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP
or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company
has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made
any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to
any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before
the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by
this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has
occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective
businesses, prospects, properties, operations, assets or financial condition, that would be required to be disclosed by the Company
under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at
least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county,
local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on Schedule 3.1(j), (i) adversely
affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could,
if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company
nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation
of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge
of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current
or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or
any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of
its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and
conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the
Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is
bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any
court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation
of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental
protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as
could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Environmental
Laws</U>.&#9;The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to
pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or
subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of
Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses,
notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental
Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws
to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or
approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens
for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP
and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by
the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the
Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights as described in the SEC Reports as necessary or required for use in connection with their respective businesses
and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual
Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)
years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited
financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual
Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have
a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is
no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except
where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at equal to $5,000,000. Neither the Company nor any Subsidiary has
any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to
obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Transactions
With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party
to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case
in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses
incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of
the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. <FONT STYLE="color: black">The
Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that:
(i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to
ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries
as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the
certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation
Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined
in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect,
the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Certain
Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are
or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have
no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject
to registration under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Registration
Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act
of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on
which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or
maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable
future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible
for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current
in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such
electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and
the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation
as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel
with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed
in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation
in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers
regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the
Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which
they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this
Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the
Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading
Market on which any of the securities of the Company are listed or designated.<U> </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the
Company of the proceeds from the sale of the Securities hereunder: (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry
on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate
all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in
respect of its liabilities when such amounts are required to be paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">The Company does not intend to incur debts beyond its ability
to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).
The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation
under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U>
sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which
the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x)
any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether
or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business;
and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Tax
Status</U>. &#9; Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and
local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it
is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the
payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent
or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person
acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision
of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(dd)</U> of the Disclosure Schedules. To the knowledge and belief
of the Company, such accounting firm: (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall
express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal
year ending December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(ee)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to
each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based
solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(ff)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<FONT STYLE="font-weight: normal; color: black"><U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(e) and 4.16 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers
has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short,
securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities
for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without
limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement
transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and
counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or indirectly, may presently
have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with
or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. </FONT>The Company further understands
and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities
are outstanding, including, without limitation, during the periods that the value of the Underlying Shares deliverable with respect
to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo;
equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges
that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(gg)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of,
any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection
with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(hh)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value
of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted
under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has
been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock
options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their
financial results or prospects.<U> </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Cybersecurity</U>.
(i)(x) <FONT STYLE="color: black">T</FONT>here has been no security breach or other compromise of or relating to any of the Company&rsquo;s
or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of
its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or
technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified
of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other
compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws
or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection
of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually
or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained
commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup
and disaster recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(jj)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer,
agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(kk)&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the
meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(ll)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act
of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly
or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or
more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither
the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(mm)&nbsp;&nbsp;&nbsp;&#9;<U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970,
as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of
the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as
of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they
shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and
performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary
corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction
Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with
the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation
and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise
in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary
course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on
which it exercises any Warrants or converts any shares of Preferred Stock it will be an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<FONT STYLE="color: black"><U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not directly
or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, executed any purchases
or sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of</FONT> the time that
such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting
forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof<FONT STYLE="color: black">.
</FONT>Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents
and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction
(including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in
order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company acknowledges and agrees that the
representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s
representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction
Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of
the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall
constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect
Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm">ARTICLE IV.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Underlying
Shares</U>. The shares of Common Stock underlying the shares of Preferred Stock shall be issued free of legends. If all or any
portion of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale of
the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise
shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration
statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale or
resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective
again and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit
the ability of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal
and state securities laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement)
registering the issuance or resale of the Warrant Shares effective during the term of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares
of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations
under the Transaction Documents, including, without limitation, its obligation to issue the Underlying Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless
of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect
that such issuance may have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Furnishing
of Information; Public Information</U>. Until the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants
have expired, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange
Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required
to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting
requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules
and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Conversion
and Exercise Procedures</U>. Each of the form of Notice of Exercise included in the Warrants and the form of Notice of Conversion
included in the Certificate of Designation set forth the totality of the procedures required of the Purchasers in order to exercise
the Warrants or convert the Preferred Stock. Without limiting the preceding sentences, no ink-original Notice of Exercise or Notice
of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise or Notice of Conversion form be required in order to exercise the Warrants or convert the Preferred Stock. No additional
legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants or convert their
Preferred Stock. The Company shall honor exercises of the Warrants and conversions of the Preferred Stock and shall deliver Underlying
Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms
of the transactions contemplated hereby and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the
Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any
of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates
or agents, including, without limitation the Placement Agent, in connection with the transactions contemplated by the Transaction
Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all
confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries
or any of their respective officers, directors, agents, employees, Affiliates or agents, including, without limitation, the Placement
Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no further
force or effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press
releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press
release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release
of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent
shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party
shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing,
the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the
Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except: (a) as required
by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent
such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior
notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.7&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any
Purchaser is an &ldquo;Acquiring Person&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities
under the Transaction Documents or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.6, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably
believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the
receipt of such information and agreed in writing with the Company to keep such information confidential. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.
To the extent that the Company any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates
delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants
and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their
respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, or a duty
to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees, Affiliates or agents,
including, without limitation, the Placement Agent, not to trade on the basis of, such material, non-public information, provided
that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document
constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
with the delivery of such notice file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.9</U> attached hereto, the Company shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion
of the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior
practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation
or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.10, the Company will indemnify and hold each Purchaser and its
directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;)
harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all
judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such
Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against
the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is
not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless
such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">warranties or covenants under
the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations
by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially
determined to constitute fraud, gross negligence or willful misconduct).&nbsp;If any action shall be brought against any Purchaser Party
in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company
in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable
to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the
extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed
after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable
opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser
Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel.
The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected
without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of
the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction
Documents. The indemnification required by this Section 4.10 shall be made by periodic payments of the amount thereof during the
course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein
shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Reservation
and Listing of Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(a)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company
shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Transaction Documents in
such amount as may then be required to fulfill its obligations in full under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;If, on any
date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum
on such date, then the Board of Directors shall use commercially reasonable efforts to amend the Company&rsquo;s certificate or
articles of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum
at such time, as soon as possible and in any event not later than the 75th day after such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;The Company
shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file with such Trading Market
an additional shares listing application covering a number of shares of Common Stock at least equal to the Required Minimum on
the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for listing or
quotation on such Trading Market as soon as possible thereafter, (iii) provide to the Purchasers evidence of such listing or quotation
and (iv) maintain the listing or quotation of such Common Stock on any date at least equal to the Required Minimum on such date
on such Trading Market or another Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely
payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer. In addition, at the Company&rsquo;s next shareholder meeting to be held (which may also be at the annual meeting of shareholders)
the Company shall put forth and include in its proxy statement a proposal for the purpose of obtaining Shareholder Approval, with
the recommendation of the Company&rsquo;s Board of Directors that such proposal be approved, and the Company shall solicit proxies
from its shareholders in connection therewith in the same manner as all other management proposals in such proxy statement and
all management-appointed proxyholders shall vote their proxies in favor of such proposal. The Company shall use its reasonable
best efforts to obtain such Shareholder Approval. If the Company does not obtain Shareholder Approval at the first meeting, the
Company shall seek Shareholder Approval at each subsequent shareholder meeting until the earlier of the date Shareholder Approval
is obtained or the Preferred Stock is no longer outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.12&#9;</FONT>RESERVED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(a)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From the
date hereof until 100 days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any
registration statement or amendment or supplement thereto, other than the Prospectus Supplement or filing of a registration statement
on Form S-8 in connection with any employee benefit plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;From the
date hereof until such time as no Purchaser holds any of the Warrants, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents
(or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means
a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise
price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares
of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or
exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or
upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market
for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity
line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities at a future determined price.
Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall
be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(c)&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless Shareholder
Approval has been obtained and deemed effective, neither the Company nor any Subsidiary shall make any issuance whatsoever of Common
Stock or Common Stock Equivalents which would cause any adjustment of the Conversion Price or the Exercise Price to the extent
the holders of Preferred Stock would not be permitted, pursuant to Section 6(e) of the Certificate of Designation to convert their
respective outstanding shares of Preferred Stock and exercise their respective Warrants in full, ignoring for such purposes the
other conversion or exercise limitations therein. Any Purchaser shall be entitled to obtain injunctive relief against the Company
to preclude any such issuance, which remedy shall be in addition to any right to collect damages. For further clarity, notwithstanding
the foregoing the Company and its Subsidiaries are not precluded from issuing securities in a Subsequent Financing that does not
require shareholder approval, but such Subsequent Financings are not excluded from the dilutive adjustment mechanisms of the Preferred
Stock or the Warrant to the extent such are otherwise applicable..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;Notwithstanding
the foregoing, this Section 4.13 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall
be an Exempt Issuance.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">4.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Participation in Future Financing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;From the date hereof until six months
from the initial Closing Date, upon any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents
for cash consideration, Indebtedness or a combination of units thereof (a &ldquo;<U>Subsequent Financing</U>&rdquo;), each Purchaser
shall have the right to participate in up to an amount of the Subsequent Financing equal to 50% of the Subsequent Financing (the
&ldquo;<U>Participation Maximum</U>&rdquo;) on the same terms, conditions and price provided for in the Subsequent Financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;&nbsp;At least five (5) Trading Days prior
to the closing of the Subsequent Financing, the Company shall deliver to each Purchaser a written notice of its intention to effect
a Subsequent Financing (&ldquo;<U>Pre-Notice</U>&rdquo;), which Pre-Notice shall ask such Purchaser if it wants to review the details
of such financing (such additional notice, a &ldquo;<U>Subsequent Financing Notice</U>&rdquo;). Upon the request of a Purchaser,
and only upon a request by such Purchaser, for a Subsequent Financing Notice, the Company shall promptly, but no later than one
(1) Trading Day after such request, deliver a Subsequent Financing Notice to such Purchaser. The Subsequent Financing Notice shall
describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised thereunder
and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet
or similar document relating thereto as an attachment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;Any Purchaser desiring to participate
in such Subsequent Financing must provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the
fifth (5<SUP>th</SUP>) Trading Day after all of the Purchasers have received the Pre-Notice that such Purchaser is willing to participate
in the Subsequent Financing, the amount of such Purchaser&rsquo;s participation, and representing and warranting that such Purchaser
has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing Notice. If the Company
receives no such notice from a Purchaser as of such fifth (5<SUP>th</SUP>) Trading Day, such Purchaser shall be deemed to have
notified the Company that it does not elect to participate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;If by 5:30 p.m. (New York City time)
on the fifth (5<SUP>th</SUP>) Trading Day after all of the Purchasers have received the Pre-Notice, notifications by the Purchasers
of their willingness to participate in the Subsequent Financing (or to cause their designees to participate) is, in the aggregate,
less than the total amount of the Subsequent Financing, then the Company may effect the remaining portion of such Subsequent Financing
on the terms and with the Persons set forth in the Subsequent Financing Notice</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;If by 5:30 p.m. (New York City time)
on the fifth (5<SUP>th</SUP>) Trading Day after all of the Purchasers have received the Pre-Notice, the Company receives responses
to a Subsequent Financing Notice from Purchasers seeking to purchase more than the aggregate amount of the Participation Maximum,
each such Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of the Participation Maximum. &ldquo;<U>Pro
Rata Portion</U>&rdquo; means the ratio of (x) the Subscription Amount of Securities purchased on the Closing Date by a Purchaser
participating under this Section 4.14 and (y) the sum of the aggregate Subscription Amounts of Securities purchased on the Closing
Date by all Purchasers participating under this Section 4.14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;The Company must provide the Purchasers
with a second Subsequent Financing Notice, and the Purchasers will again have the right of participation set forth above in this
Section 4.14, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated for any reason
on the terms set forth in such Subsequent Financing Notice within thirty (30) Trading Days after the date of the initial Subsequent
Financing Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;The Company and each Purchaser agree
that if any Purchaser elects to participate in the Subsequent Financing, the transaction documents related to the Subsequent Financing
shall not include any term or provision that, directly or indirectly, will, or is intended to, exclude one or more of the Purchasers
from participating in a Subsequent Financing, including, but not limited to, provisions whereby such Purchaser shall be required
to agree to any restrictions on trading as to any of the Securities purchased hereunder or be required to consent to any amendment
to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written
consent of such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 36pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;Notwithstanding anything to the contrary
in this Section 4.14 and unless otherwise agreed to by such Purchaser, the Company shall either confirm in writing to such Purchaser
that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its intention to issue
the securities in the Subsequent Financing, in either case in such a manner such that such Purchaser will not be in possession
of any material, non-public information, by the tenth (10<SUP>th</SUP>) Business Day following delivery of the Subsequent Financing
Notice. If by such tenth (10<SUP>th</SUP>) Business Day, no public disclosure regarding a transaction with respect to the Subsequent
Financing has been made, and no notice regarding the abandonment of such transaction has been received by such Purchaser, such
transaction shall be deemed to have been abandoned and such Purchaser shall not be deemed to be in possession of any material,
non-public information with respect to the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt; text-align: justify"><FONT STYLE="color: black">4.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to such Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to
treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect
to the purchase, disposition or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">4.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither
it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending
at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.6. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time
as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release
as described in Section 4.6, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and
the information included in the Disclosure Schedules (other than as disclosed to its legal and other representatives). Notwithstanding
the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and
agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.6, (ii) no Purchaser shall be restricted or prohibited from effecting
any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in
Section 4.6 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company
to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agent, including,
without limitation, the Placement Agent, after the issuance of the initial press release as described in Section 4.6. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions
made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only
apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the
Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt; text-align: justify">4.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<U>Lock-Up Agreements</U>. The Company
shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up
period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement
breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of
the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm">ARTICLE V.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect
whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing
has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Fees
and Expenses</U>. At the Closing, the Company has agreed to reimburse Alpha Capital Anstalt (&ldquo;Alpha&rdquo;) the non-accountable
sum of $80,000 for its legal fees and expenses. Accordingly, in lieu of the foregoing payments, the aggregate amount that Alpha
is to pay for the Securities at the Closing shall be reduced by $80,000 in lieu thereof. Except as expressly set forth in the Transaction
Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day
processing of any instruction letter delivered by the Company and any conversion or exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York
City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day
or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date
of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and Purchasers which purchased at least 67% in interest of the Preferred Stock based
on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or
a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any
right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations
of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in
accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to
whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>No
Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action
or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding
is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under
Section 4.10, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action
or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an
original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of)
any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the
case of a rescission of a conversion of the Preferred Stock or exercise of a Warrant, the applicable Purchaser shall be required
to return any shares of Common Stock subject to any such rescinded conversion or exercise notice concurrently with the return to
such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s
right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate
evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or
in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation
the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from,
disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person
under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.17&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Usury</U>.
To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and
will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any
time hereafter in force, in connection with any Action or Proceeding that may be brought by any Purchaser in order to enforce any
right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document,
it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the
nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the &ldquo;<U>Maximum Rate</U>&rdquo;),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated
with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such
Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents
is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract
rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the Closing Date thereof
forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in excess of the
Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction Documents, such
excess shall be applied by such Purchaser to the unpaid principal balance of any such indebtedness or be refunded to the Company,
the manner of handling such excess to be at such Purchaser&rsquo;s election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any
other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the
Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the
rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser
to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate
legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each
Purchaser and its respective counsel have chosen to communicate with the Company through EGS. EGS does not represent any of the
Purchasers and only represents Alpha. The Company has elected to provide all Purchasers with the same terms and Transaction Documents
for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly
understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company
and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other
amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Saturdays,
Sundays, Holidays, etc</U>.&#9;If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><FONT STYLE="color: black">5.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;</FONT><B><U>WAIVER
OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><I></I></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0cm"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">IN WITNESS WHEREOF, the
parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as
of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD COLSPAN="2" STYLE="padding: 0; line-height: 107%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AGEAGLE AERIAL SYSTEMS, INC.</B></FONT></TD>
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Address for Notice:</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="2" STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0; width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0; width: 45%; border-bottom: Black 1pt solid">/s/ Nicole Fernandez-McGovern</TD>
<TD STYLE="padding: 0; text-indent: 0; width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0; width: 45%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>E-mail:</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0">&nbsp;</TD>
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
</FONT>Nicole Fernandez-McGovern</TD>
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0">&nbsp;</TD>
<TD STYLE="padding: 0; line-height: 107%; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
</FONT>CFO</TD>
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="2" STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</FONT></TD>
<TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="line-height: 107%; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">[PURCHASER
SIGNATURE PAGES TO UAVS SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">IN WITNESS WHEREOF, the
undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Purchaser: _____<U>Alpha Capital Anstalt</U>___________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
____<U>/s/ Nicola Feuerstein</U>______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Name of Authorized Signatory: _______<U>Nicola
Feuerstein</U>_____________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Title of Authorized Signatory: _________<U>Director</U>____________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Email Address of Authorized Signatory: ____<U>info@alphacapital.li</U>_________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Address for Notice to Purchaser: &#9;</P>

<P STYLE="text-indent: 2in; font: 10pt Times New Roman, Times, Serif; margin: 0pt">Altenbach 8</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in">FL-9490 Vaduz</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in">Principality of Liechtenstein</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in">LH Financial Services Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in">510 Madison Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in">Suite 1400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 2in">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Subscription Amount: $_<U>10,000,000</U>____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Shares of Preferred Stock: ____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Warrant Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">41</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex10_2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT><B>Exhibit
10.2&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LOCKUP
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
26, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
agreement (the &ldquo;<B>Lockup Agreement</B>&rdquo;) is being delivered to you by the undersigned shareholder of the Company (the &ldquo;<B>Shareholder</B>&rdquo;)
in connection with an understanding by and between AgEagle Aerial Systems, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;),
and Alpha Capital Anstalt or its assigns (the &ldquo;<B>Holder</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is hereby made to (a) the Securities Purchase Agreement, dated June 26, 2022 (the &ldquo;<B>Purchase Agreement</B>&rdquo;), by and between
the Company and the Holder pursuant to which the Holder acquired shares (&ldquo;<B>Shares</B>&rdquo;) of Series F Preferred Stock of
the Company. Capitalized terms used herein but not defined herein shall have the meaning as set forth in the Purchase Agreement. The
Company, as a condition to the Holder&rsquo;s purchase of the Shares, is requiring this Lockup Agreement from all officers and directors
of the Company&rsquo;s common stock or convertible equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shareholder agrees with the Company and the Holder that, for a period of 100 days from the date hereof (such period, the &ldquo;<B>Restricted
Period</B>&rdquo;), neither the Shareholder, nor any Affiliate of the Shareholder which has or shares discretion relating to the Shareholder&rsquo;s
investments or trading or information concerning the Shareholder&rsquo;s investments, including in respect of the shares of common stock
(together, the &ldquo;<B>Shareholder&rsquo;s Trading Affiliates</B>&rdquo;), collectively, shall not sell, dispose or otherwise transfer,
directly or indirectly, (including, without limitation, any sales, short sales, swaps or any derivative transactions that would be equivalent
to any sales or short positions) any shares of Common Stock, or shares of Common Stock underlying any Common Stock Equivalents held by
the Shareholder on the date hereof (collectively, the &ldquo;<B>Restricted Securities</B>&rdquo;) other than up to $250,000 worth of
shares pursuant to a 10b-5(1) plan, after which time, the restrictions set forth in this Lockup Agreement shall cease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, during the Restricted Period, the Shareholder may, directly or indirectly, sell or transfer all, or
any part, of the Restricted Securities to any Person (an &ldquo;<B>Assignee</B>&rdquo;) in a transaction which does not need to be reported
on the NYSE American consolidated tape, without complying with (or otherwise limited by) the restrictions set forth in this Lockup Agreement;
provided that, as a condition to any such sale or transfer an authorized signatory of the Company and such Assignee duly execute and
deliver a Lockup agreement in the form of this Lockup Agreement (an &ldquo;<B>Assignee Agreement</B>&rdquo;, and each such transfer a
&ldquo;<B>Permitted Transfer</B>&rdquo;) and, subsequent to a Permitted Transfer, sales of the Shareholder and the Shareholder r&rsquo;s
Trading Affiliates and all Assignees (other than any such sales that constitute Permitted Transfers) shall be aggregated for all purposes
of this Lockup Agreement and all Assignee Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Lockup Agreement must be
in writing and shall be given in accordance with the terms of the Purchase Agreement, provided that, with respect to any notices, consents,
waivers or other communications to be made by the Company to the Shareholder, such notice, consent, waiver or other communication shall
be delivered to the Shareholder at the e-mail address or facsimile number on the signature page hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lockup Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all
prior negotiations, letters and understandings relating to the subject matter hereof and are fully binding on the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lockup Agreement may be executed simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and
all such counterparts shall constitute one and the same instrument. This Lockup Agreement may be executed and accepted by facsimile or
PDF signature and any such signature shall be of the same force and effect as an original signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of this Lockup Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective
successors and assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lockup Agreement may not be amended or modified except in writing signed by each of the parties hereto, including the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
questions concerning the construction, validity, enforcement and interpretation of this Lockup Agreement shall be governed by the applicable
provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
party hereto acknowledges that, in view of the uniqueness of the transactions contemplated by this Lockup Agreement, the other party
or parties hereto will not have an adequate remedy at law for money damages in the event that this Lockup Agreement has not been performed
in accordance with its terms, and therefore agrees that such other party or parties, including, without limitation, the Holder, shall
be entitled to seek specific enforcement of the terms hereof in addition to any other remedy it may seek, at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligations of the Shareholder under this Lockup Agreement are several and not joint with the obligations of any other signatory under
any other similar agreement, and the Shareholder shall not be responsible in any way for the performance of the obligations of any other
person under any such other agreement. Nothing contained in this Lockup Agreement, and no action taken by the Holder or the Company pursuant
hereto, shall be deemed to constitute the Holder and the Shareholder as a partnership, an association, a joint venture or any other kind
of entity, or create a presumption that the Holder and the Company or the Shareholder are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by this Lockup Agreement and the Company acknowledges that the Holder
and the Shareholder are not acting in concert or as a group with respect to such obligations or the transactions contemplated by this
Lockup Agreement or any other agreement. The Company and the Shareholder confirm that the Shareholder has independently participated
in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[The
remainder of the page is intentionally left blank]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto have executed this UAVS Lockup Agreement as of the date first set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgEagle
Aerial Systems, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Barrett Mooney&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
<TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barrett Mooney</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
<TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Agreed to and Acknowledged:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;SHAREHOLDER&rdquo;</B></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Barrett
    Mooney</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Barrett Mooney</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Nicole Fernandez-McGovern</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nicole Fernandez-McGovern</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Grant Begley</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Grant Begley</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Luisa Ingargiola</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Luisa Ingargiola</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Thomas Gardner</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Thomas Gardner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page to UAVS Lockup]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex99_1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="text-align: right; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0"></P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Source:
<I>AgEagle Aerial Systems, Inc.</I><BR>
<I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>June 27, 2022 09:22 ET </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgEagle
Aerial Systems Announces Pricing of $10 Million Registered Direct Offering</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WICHITA,
Kan., June 27, 2022 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE American: UAVS) (&ldquo;AgEagle&rdquo; or the &ldquo;Company&rdquo;),
an industry-leading provider of full-stack drone, sensor and software solutions for commercial and government/defense use, today announced
that, it has entered into a securities purchase agreement with an institutional investment firm (the &ldquo;Investor&rdquo;), which is
an existing AgEagle shareholder. Pursuant to the agreement, the Investor will purchase 10,000 shares of Series F 5% Convertible Preferred
Stock (the &ldquo;Series F Convertible Preferred&rdquo;) and warrants to purchase up to 10,416,667 shares of common stock at an exercise
price of $0.96 per share (the &ldquo;Warrants&rdquo;), for gross proceeds of approximately $10 million. The Series F Convertible Preferred
will be convertible into 16,129,032 shares of the Company&rsquo;s common stock at a conversion price of $0.62 per share. The Warrants
are not exercisable for the first six months after issuance and have a three-year term from the exercise date. Upon exercise of the Warrants
in full by the Investor, the Company would receive additional gross proceeds of approximately $10 million. A certificate of designation
setting forth the terms, dividends, rights and other privileges of the Series F Convertible Preferred will be filed with the Secretary
of State of the State of Nevada. The Investor has the right, subject to certain conditions, including shareholder approval, to purchase
up to $25,000,000 of additional shares of Series F Convertible Preferred and warrants. That option will be available for a period of
18 months after shareholder approval at a purchase price equal to the average&nbsp;Volume Weighted Average Pricings (&ldquo;VWAPs&rdquo;)
for three trading days prior to the date the Investor gives notice to the Company that it will exercise the option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects the net proceeds from the offering to be approximately $9.92 million after deducting approximately $80,000 in offering
expenses. The Company expects to spend the balance of the proceeds for general working capital and capital expenditure purposes. The
offering is expected to close on or about June 29, 2022, subject to the satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commenting
on the financing, Nicole Fernandez-McGovern, CFO of AgEagle, noted, &ldquo;We are very pleased to be proceeding with this offering, which,
upon closing, will further strengthen the Company&rsquo;s liquidity position.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities
in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of such jurisdiction. A registration statement relating to the offered securities (File Number 333-252801) has been declared effective
by the Securities and Exchange Commission. A prospectus supplement relating to the securities will be filed by the Company with the SEC.
When available, copies of the prospectus supplement relating to the registered direct offering, together with the accompanying prospectus,
can be obtained at the SEC&rsquo;s website at <B>www.sec.gov</B>. For more detailed information relating to this transaction, please
refer to the related Form 8-K to be filed with the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
AgEagle Aerial Systems Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgEagle
and its wholly owned subsidiaries are actively engaged in designing and delivering best-in-class drones, sensors and software that solve
important problems for our customers. Founded in 2010, AgEagle was originally formed to pioneer proprietary, professional-grade, fixed-winged
drones and aerial imagery-based data collection and analytics solutions for the agriculture industry. Today, AgEagle is a leading provider
of full stack drone solutions for customers worldwide in the energy, construction, agriculture, and government verticals. For additional
information, please visit our websites at www.ageagle.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Forward-Looking
Statements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Such statements involve risks and uncertainties that could negatively affect our
business, operating results, financial condition, and stock price. Factors that could cause actual results to differ materially from
management&rsquo;s current expectations include those risks and uncertainties relating to our competitive position, the industry environment,
potential growth opportunities, and the effects of regulation and events outside of our control, such as natural disasters, wars, or
health epidemics. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking
statements contained herein to reflect any change in our expectations or any changes in events, conditions, or circumstances on which
any such statement is based, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgEagle
Aerial Systems Contacts:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
<TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor Relations:<BR>
Gateway Investor Relations<BR> Matt Glover or Cody Cree<BR> Phone: 949-574-3860<BR> Email: UAVS@gatewayIR.com</FONT></TD>
<TD STYLE="text-indent: 0pt; padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Media Inquiries:<BR>
media@ageagle.com</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please visit <B><U>www.ageagle.com</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ex99_2.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="text-align: right; font: 10pt/14.5pt Helvetica LT Std,sans-serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt/14.5pt Helvetica LT Std,sans-serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt/14.5pt Helvetica LT Std,sans-serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 14pt Helvetica LT Pro,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 14pt Helvetica LT Pro,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORRECTING
AND REPLACING:</B></FONT></P>

<P STYLE="font: 14pt Helvetica LT Pro,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AgEagle
Aerial Systems Announces Pricing of </B></FONT></P>

<P STYLE="font: 14pt Helvetica LT Pro,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$10
Million Registered Direct Offering</B></FONT></P>

<P STYLE="font: 8pt Helvetica LT Pro,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Pro,sans-serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>WICHITA,
Kan. &ndash; (GLOBE NEWSWIRE) -- June 30, 2022</I></B> &mdash; AgEagle Aerial Systems Inc. (NYSE American: UAVS) (&ldquo;AgEagle&rdquo;
or the &ldquo;Company&rdquo;), an industry-leading provider of full-stack drone, sensor and software solutions for commercial and government/defense
use, today announced that, it has entered into a securities purchase agreement with an institutional investment firm (the &ldquo;Investor&rdquo;),
which is an existing AgEagle shareholder. Pursuant to the agreement, the Investor will purchase 10,000 shares of Series F 5% Convertible
Preferred Stock (the &ldquo;Series F Convertible Preferred&rdquo;) and warrants to purchase up to 16,129,032 shares of common stock at
an exercise price of $0.96 per share (the &ldquo;Warrants&rdquo;), for gross proceeds of approximately $10 million. The Series F Convertible
Preferred will be convertible into 16,129,032 shares of the Company&rsquo;s common stock at a conversion price of $0.62 per share. The
Warrants are not exercisable for the first six months after issuance and have a three-year term from the exercise date. Upon exercise
of the Warrants in full by the Investor, the Company would receive additional gross proceeds of approximately $15.5 million. A
certificate of designation setting forth the terms, dividends, rights and other privileges of the Series F Convertible Preferred will
be filed with the Secretary of State of the State of Nevada. The Investor has the right, subject to certain conditions, including shareholder
approval, to purchase up to $25,000,000 of additional shares of Series F Convertible Preferred and warrants. That option will be available
for a period of 18 months after shareholder approval at a purchase price equal to the average Volume Weighted Average Pricings (&ldquo;VWAPs&rdquo;)
for three trading days prior to the date the Investor gives notice to the Company that it will exercise the option.</FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Pro,sans-serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects the net proceeds from the offering to be approximately $9.92 million after deducting approximately $80,000 in offering
expenses. The Company expects to spend the balance of the proceeds for general working capital and capital expenditure purposes. The
offering is expected to close on or about June 29, 2022, subject to the satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Pro,sans-serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commenting
on the financing, Nicole Fernandez-McGovern, CFO of AgEagle, noted, &ldquo;We are very pleased to be proceeding with this offering, which,
upon closing, will further strengthen the Company&rsquo;s liquidity position.&rdquo;</FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Pro,sans-serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities
in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of such jurisdiction. A registration statement relating to the offered securities (File Number 333-252801) has been declared effective
by the Securities and Exchange Commission. A prospectus supplement relating to the securities will be filed by the Company with the SEC.
When available, copies of the prospectus supplement relating to the registered direct offering, together with the accompanying prospectus,
can be obtained at the SEC&rsquo;s website at&nbsp;<FONT STYLE="color: #0563C1">www.sec.gov.</FONT>&nbsp;For more detailed information
relating to this transaction, please refer to the related Form 8-K to be filed with the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Pro,sans-serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About&nbsp;AgEagle&nbsp;Aerial&nbsp;Systems&nbsp;Inc.</B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Pro,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgEagle
and its wholly owned subsidiaries are actively engaged in designing and delivering best-in-class drones, sensors and software that solve
important problems for our customers. Founded in 2010, AgEagle was originally formed to pioneer proprietary, professional-grade, fixed-winged
drones and aerial imagery-based data collection and analytics solutions for the agriculture industry. Today, AgEagle is a leading provider
of full stack drone solutions for customers worldwide in the energy, construction, agriculture, and government verticals. For additional
information, please visit our websites at www</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Helvetica LT Pro,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Forward-Looking
Statements</I></B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
press release may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Such statements involve risks and uncertainties that could negatively affect our
business, operating results, financial condition, and stock price. Factors that could cause actual results to differ materially from
management&rsquo;s current expectations include those risks and uncertainties relating to our competitive position, the industry environment,
potential growth opportunities, and the effects of regulation and events outside of our control, such as natural disasters, wars, or
health epidemics. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking
statements contained herein to reflect any change in our expectations or any changes in events, conditions, or circumstances on which
any such statement is based, except as required by law.</I></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AgEagle
Aerial Systems Contacts:</U></B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations:&#9;Media Inquiries:</B></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gateway
Group, Inc. &#9; <FONT STYLE="color: #00642D"><B>media@ageagle.com</B></FONT></FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matt
Glover or Cody Cree&#9;</FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
949-574-3860&#9;</FONT></P>

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<FONT STYLE="color: #00642D"><B>UAVS@gatewayIR.com</B>&#9;</FONT></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Helvetica LT Std,sans-serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="color: #00642D"></FONT></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>uavs-20220626.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9qJZs7xRiXgOn8uMb3VcSaOPyaP9zJFxyZkhtmR8fVnaryIvfDdYvCtiQ5JGEU8L -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:UAVS="http://ageagle.com/20220626" elementFormDefault="qualified" targetNamespace="http://ageagle.com/20220626">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://ageagle.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="uavs-20220626_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="uavs-20220626_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>uavs-20220626_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>uavs-20220626_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ageagle.com/role/Cover" xlink:href="uavs-20220626.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ageagle.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140614885255744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 26,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AGEAGLE
AERIAL SYSTEMS INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000008504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0422242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8833 E. 34th Street North<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wichita<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">67226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(620)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">325-6363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UAVS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>uavs_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="uavs-20220626.xsd" xlink:type="simple"/>
    <context id="From2022-06-26to2022-06-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000008504</identifier>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-06-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-06-26to2022-06-26">0000008504</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-06-26to2022-06-26">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-06-26to2022-06-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2022-06-26to2022-06-26">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-06-26to2022-06-26">2022-06-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-06-26to2022-06-26">AGEAGLE AERIAL SYSTEMS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-06-26to2022-06-26">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-06-26to2022-06-26">001-36492</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-06-26to2022-06-26">88-0422242</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-06-26to2022-06-26">8833 E. 34th Street North</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-06-26to2022-06-26">Wichita</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-06-26to2022-06-26">KS</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-06-26to2022-06-26">67226</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-06-26to2022-06-26">(620)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-06-26to2022-06-26">325-6363</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-06-26to2022-06-26">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-06-26to2022-06-26">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-06-26to2022-06-26">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-06-26to2022-06-26">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-06-26to2022-06-26">Common     Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-06-26to2022-06-26">UAVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-06-26to2022-06-26">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-06-26to2022-06-26">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" # 6MY4%XL'EW$$   F$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V847/B-A#'W^]3:-Q.YVXF@"T((2DP0S@NI4DX)N:223M]$+; FMB63Y8A
M^?9=&;#3U*SA 2S;^_=/NZM=F?Y6JI<TX%R3URB,TX$5:)U<M5JI%_"(I4V9
M\!BNK*2*F(:A6K?21''FYT91V**VW6U%3,36L)^?FZMA7V8Z%#&?*Y)F4<34
MVS4/Y79@.=;AQ(-8!]J<: W["5MSE^L?R5S!J%6H^"+B<2ID3!1?#:R1<W5-
MSXU!?L>CX-OTW3$Q4UE*^6(&4W]@V8:(A]S31H+!SX:/>1@:)>#XN1>UBF<:
MP_?'!_5O^>1A,DN6\K$,GX2O@X'5LXC/5RP+]8/<_L'W$\H!/1FF^3?9[N[M
M="SB9:F6T=X8""(1[W[9Z]X1IQC0O0'-N7</RBF_,LV&?26W1)F[0<T<Y%/-
MK0%.Q"8JKE9P58"='H[EAJM^2X.4.='R]F;7.S-ZQ.S/+&X2VCTCU*;TO^8M
M("@P:(%!<[TVAD'^'BU3K2!0_U01[10ZU0HF>Z_2A'E\8$%ZIEQMN#7\[1>G
M:_^.\+4+OC:F/OPJO0QR49/%6\*KX'#S7N,6@>@4$!U4900$?D[Q+63K*@K<
M?L7"E",<YP7'^6G.F',EI$\FL4\@^2K]@BL5:5271]T"K8L*CC.E<@>)U&,A
M>>9,H7BX6J/AT$;;0;@N"JX+5&D2:Z'? "OD9)9%R^HUAVO8MM-H=SN7F)]Z
M!4_O%)X'OA9FQ8''9BRJ]!"N,[J9C&[N)I]&DX?IZ(ZXS^YB<N^2Z6S<1"@O
M"\K+4RC'$%$%T9S&/G\EM_RMBA-7LO-/[]SN(%B.719-^Q2P!7LE4Q_HQ$IX
M+.\RQX-;(]GK->P.I;2#A==Y5]:=4PBGL2=5(E4.=T9<#>N 2$7&,@.?@FNE
M7QGU&O79(P99%GT'K=D'R)'O0\5.SPX'Y [N(]_C:C)<LM=KM\FD2=H='<!T
ME=G8S*32 09<=@$'K^,?@<=F!.Y<R&U<"8O+/0DO$)IA:&5O</#B_A&M"/5<
MR8V(O6IGXIJW+H96M@L'K_(?T>8RU;"<_Q+)\?S#%;L7E'8QMK)?.#4-(R>#
M_>QQ%%S@<Y?:7S"4LD4X>'V_DZ9ES0,98SVB1J1-SQO==K>-$95-PL&K^Y,2
M6O,87!-%6;PO<6DE%2Y4M_-PRH[@X(7<E:'PA!;QFMQ#@BO!PDH>7*6.AY:=
M@.)E>ZYXPP/W<%AANPTB[-%@*_M]M:J.7XU>+5G9 2A>H_]'-DW3#,AJ 7'9
M6L!W6WZ\5"^$AMV07!&'?EY^(2[W,LBWRN9>HV3R4\:?"'Q<+;V7,Y+ OF_#
MPHR37^VF[9 $9IP&3*'D91N@>-U>*.:;#'3?HJ6LS+\:@1^C1ZRTTK+J4[Q"
M'YQ&)J]>P.(U/[J/JQ&:/;L3C*@L]O2D8C^)N%H;']V  K1B"%'"XNK@XH)'
M$Z[U[JW7_(-PS\P34Q+R%0C9S0O05;N7\MU RR1_$5Y*#:_5^6' &2P&<P-<
M7TFI#P/S;EW\-3+\%U!+ P04    " # 6MY4GZ ;\+$"  #B#   #0   'AL
M+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%D
MN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I
M#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#
M;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F?
M KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0
M&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH
M!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?
MA+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+
M"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TU
MMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%
M.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E
M=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$
M#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$#
M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " # 6MY4EXJ[',
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MZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " # 6MY4)!Z;HJT
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M2P$"% ,4    " # 6MY4!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,!:WE2$E5$D[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M ,!:WE297)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ P%K>5!>+!Y=Q!   )A$  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M ,!:WE2?H!OPL0(  .(,   -              "  ;4,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ P%K>5)>*NQS     $P(   L              ( !
MD0\  %]R96QS+RYR96QS4$L! A0#%     @ P%K>5*K$(A8S 0  (@(   \
M             ( !>A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,!:
MWE0D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,!:WE1ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="uavs_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ageagle.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="uavs_8k.htm">uavs_8k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex10_2.htm</File>
    <File>ex3-1.htm</File>
    <File>ex4_1.htm</File>
    <File>ex5-1.htm</File>
    <File>ex99_1.htm</File>
    <File>ex99_2.htm</File>
    <File>uavs-20220626.xsd</File>
    <File>uavs-20220626_lab.xml</File>
    <File>uavs-20220626_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "uavs_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "uavs_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "uavs-20220626_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "uavs-20220626_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "uavs-20220626.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "UAVS",
   "nsuri": "http://ageagle.com/20220626",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "uavs_8k.htm",
      "contextRef": "From2022-06-26to2022-06-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://ageagle.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "uavs_8k.htm",
      "contextRef": "From2022-06-26to2022-06-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ageagle.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001575705-22-000462-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001575705-22-000462-xbrl.zip
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M&0H9,7?/R1,,SW<3>M'%KX!?7B9\R.5P2NI>?\ZI&E =MDOE[9"LV/W2ZL2
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MD-R0+MNH)]GHY.@(E^2]5U'.__+6L/H'F:L3E_,Q'K4IR5T&")-UDT.$DO/
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MU"C)?%Z)6^HQ>D!>P"J .OP"UA,NVG(-/WY9$:/X^1H,HNC)XR.XCE^FB,A
MEG&P'Y-Y&7UW='+T3'9(A,76<MLR-KK)#_\SS?/-_Y=*KP]GY=*3\WO?WM;^
M/_BMX5V+@TS/WB&ZE<)IF.49XW1S2J;VG,\=O V*BQ!0)+\, 'U][P/!D&?I
M6G\_2^HKK)ZBI"J4$)-B23JQ]+LDTY'GF!Z/6B33NE_V9.%#6^B_DRICN!FF
M>5E/]XY^HL_ Y3[F%,:]AP37X:\MJA3QORW$GO%P0V8@FZ<XH>2SEB %4R!T
M[+]9GJSK5&M]HU,DK;D>>+;H-?\(F\@V(#E(Q @DVNO02H_% 8+D1-=E#AI
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M(:D4L(0@-2NLM@C/TA3QM A6]H$:YI/??KO+7?V6P-T,J118ZBGGV$MEQ;M
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MHC /J4:TW;T "9]#!-_V(ZV4H\EUF;%+')J9E^MI0X5,KX0E0U,/A.Z)=V7
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M\YJ[A+7A"K<)" F[YLDIY]+P<)(EO=]>HK& --VC@H9#:8PUA-"AS5[J&8=
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M%C=V7+!]L@89EGLZMJ 0'W;")[*Q0\QVW2N96- RS])KS@_T#[B)[W?8Q9%
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MTR3X6:3AR^Y>7JL+%-I:R7L\J1"B)UW@KY<6%8&46$&8]DZRRK"\A0-6>E0
M.:/K5'WU_!YV6/H,K":K%XFC>R>W-V<PVDKG04'&>3K%S+O&D;NLDHTR/K.T
M@P]0^KCT?.5OC3Q]:U_# :^;>!%=64[D^)OZCE?I',2V[798D+T*_SX#<_,:
MYI7D_61F)B!MFMP15I,\,HDO<'%*:(_LO<F<RM%?9V7N8.BO7KP[Q==AY4;K
M0_U''\HO-\_WZ',!TRT^;CR<K1(<YR&V/;2R P83[$]X),G<4-)OMH#1W]*6
MXE+U!Y1"KT!XK<) AO$F3)?3-*09\CHF:W1DP$Q<S-181<HM'2W67':4^.53
MMX%!'RMS)=UB.TIK5#(^.FOPZ!6M4$T2D>=6+TGZ54AO0A]AO6\:.+=\<U6Z
MDGTMW7,\FA@01D\9S..G_5!RF@$'-S_JRS@X\.4P;Y]NJ?_:-^_D"G,S_TG3
M'>TRVQ3M^*3I=K^P)?R437R"2P%388HE^0WY#L-YMDH2IM542S)'%XQW<?@%
M(GC$,ZYE'%C1]\"%F/V(M59WQE 9_6:>+&%VZ?-:3'PDXRSJD+J/,!*F^GBR
MQ PVI/G*YJR[J)BEIK ^DV_0U*V&R[.LBG3C*@8L],CPSU'M)X(RE[BGVBQ.
MHG5/TO10%EJ]UKP$Z.^:./X337QD7D-;FIS">84O^;ZPH(86M5!L>(5B:[65
MQL\6LL:YS)P^]J+,HB$&/7H<(E.F'4(SDCX^UQP^CL.&4Y$)%! =-LDJF67"
MW>,'MQ3O2&@X6;:S*=O>)F6OG4R-XB+CTX#.X5-;A+EEN=+Z],?=/\N?I<6.
M) JJDX0LK3EF>8$)AH%'1 LEWKWC5[NOFY["JK7^#T+QWB7$^-T^Q+A+B/&[
M?8AQ'V*\VTL-<QUY6]393I8@2_K!FR+ (?IHD*]BTB?L?.:V<ZIS9IL5^]RV
M,X1J0KWTMH8BE9@OX)E^6(SKJE3,[*G4Q$T)27W-,!F0Y:!P9$C]C?Z@><J0
MP=35!Q/ZND65K.=Q=%DAQW617L*4IT)Y@:K_8IU'RZR6=Q\<\B*_7M@KUGEP
MIE6YQES]_F3Y=PS$"I,NI=-L7\CL(D<"-Q1F]%I]H$,NRG/0S\]B[F!ZO\0'
MAHK*T^J2/J.4C$E=KY>"+$L7J-YQ, ,'@+M XRSB=L4R.K.KDO%G!JJ3S-!-
M@IJ<\]JV!G 8G7;G;+!;K+M[ZE_MAF@R]H8GGP$J.ECPITD=87MK.!AM%KH8
MU2Q5GS6J.+_%USYLQ(%*/QS2$A33I^$<ZV^=2 H\#XBIG&1^75$SK6A%6SLL
MUM;2'-WRNM1Z%T# JH\)9I2#5<3Q:ZM>"T<V*EB4PN\6GK%3,E62%B^3[Y:^
M<K6R@HEOA+_*<4+[]X$BS(DX'(^@=F*K=J'?-,]FY&JU,18!FMH(]:IDN$!;
MY?0<S_[[MJ$JNN9MH#9RT=:@&=:992DR\]>[9XJ2J].3+PSQT"PN6WNVE>A-
M7@=4DZEZF&/F[SD;!B/GC87)AEU8B?")BPL+-?3NMB2/,NX(BW-L.]]Z<8^*
M<O7^Q&D:XEM[P*W/::O\O85*!#,=3Q[15S<] 0DR4<4,5;,3&_*%!Q%PTC#L
M8\M\>6]BRX#CNW(W"R[J-^!Z3_V=++D@DP'W0ZO:7"N/I>6X\OM4>\0'&JO@
ML0_6A0;8 '="QK,VV1I:S57:,J=I%4D*<#5'+:,(2Y!SD6O'D4]PE91M:NAP
M,)PFT#O:'+.6(,XG<^AZS@@'BLOFBCTKB,<1Y?2=$[V36[$E6H+:92<8!T@(
M5_;<1>I)M'?SO97R^\*US>V>W+M3-K;J*\-J78L7%Q?D9RE0RTY#40G)H_NO
M.]>?6%/X3E#!"ZON\5ER5#GDVH)I3MD)B-I:N_KK "4FU4C4Y*DMC%?&QJ"S
M3+H BYN$6<4:$ADF*:_!S)U\09[V5EU=Z#+5#[X%RO9'(&O_'0MIPO9YO8A%
MC0)CB KY4HAQC2YQDIE&HUQCEHJ0<T["(LAXN]/^F1\,;12XE<C+S)4=KI!O
M4-;Y%]#VEE@XMBQ\A?"8]P/^\*<RJ4C]?*E>?1,1I<HM%=MS5NDR+(C,--^G
MOLQLVG^%U3L;K# B'F-;OQJIWHI9E:H.>/L,#4P#]J>),#FH&9@%Q>MP!2:J
M%(4K5*.RRCJFE.;&"PCYFQHFK4P:5S<#VOWV:8,3J:10;EX?Z)'8R1_Y;.^/
MW,4?^6SOC_SB_)'_<@=RUZJ7[J;JJB\Q)D)ZV!J7.K?I_2@GH=L%)7R%F?Z^
MR',[K0\LO14E&UBJ/I:?X4]1&S4L(BKP<U%/;:US8M_F *^_. 8N"'<[0(\1
MNUWV7A-4?Y,\53909MZI;A[*IT4D7).NT),Y@SL8037H[DP<SF?XLIJFPF:&
MC-QD68OV#=<E7*):W*/HFZ'>RZMQ61*QN(9<6F"')"'%SVU6OG][Y%[.5L$D
MNSX(J1_[?NL:"G$_?)?25.X\_?Y*]8I+:_CD:G'6O/FFE=LM2-T6=64*ARCK
MT$^'FG>:@T)4E06F!E#D<T$Z #F<Z8F7*;FX,)/UHH+C& (HI<9]C:Z1K$;X
M&6@_2<7H0J?\W K%G?Z_]J[]IXTD6_]NR?]#*]J10'(8\IK7SD;7@)-PEP#"
M,-GH:K5JW&WHB>VVNFT2]J^_=5Y5IZJ[C9U $@;OU=TE8'=75U>=.H_O?-\U
MLV&V6PK5->2'NFD8BE?OII'4]<(2BWS-/ 2D#W%]!FMB3)/'W3=.4ZGJGP.'
MYLBL+<IG09 2C\I<)7>-<8%5(M^17<T@D\VZWN;I7*" Y,91UW)&S0QF*WRZ
M5LW40,"2FZEC,7JT7 390Q "4@M:QF%^@"Z3#]*[D@06*1PF<4TVU,Y%C:/M
MX.-V(,HB-)4*A&X2'@=S)C:JU-,3O$TT#*3Z.F&8X3@5^PUI)=!+P&5"&G0X
M03*JTB:8*U,(4K 4[,JW'IOQYQDV5."G93PT^*M\)H1-/'X,-^.KO%#L('3;
M)B)VTJUU&>V0F)W)8O%:=>\.A0[TO"9YR@("],VZ+\FB)%E*7I,!)PV_GS3]
MT'@)3( J1LJZS3%O(OE%&UIWY79+<V'R6J[(0,,S1J-\ IUO"E+Y5PA:;BN=
M]E2EQTYZ_=[)'[V]>YSYNJUI687UVN?0LBN]W0+ KSEM43ULG5%<\-^O&'9.
M22-AFB:K8$(A2#R4BC9KETE']C"QLX@[QC9T6)(R\.E):@,C+N 0SGV, E:-
MJ?:'5YGD<_ 9L4ZAI"K(9D,KG.)Z8IM8Y_PN0(-;@G)B,(.(I$%C P8$YZ[\
MHYP;%SUUI5R ^BM0/!E%TA*?0Z.2_30 (2SC1Y.D!WJBV'W2?_Q+G;.$*2.&
MMIJ#?)(.X90>Q;?$-7S_HM#E,Z6+EKS-UT4HFZW%7<TI6&I\HM UUG5XG",(
M'9GL4/_(W- U]F!_/JFP $P!-X'JRW:2IECNER6^-._;*LN_W4())=UY'^%<
MP$6Y> B1^%4^NJ*H]P]S#TS+GL#<J5S]ED(I-WY(X941,@[]4QKHZ6KT^EFM
MY2 AR!1KD>!*02<*S"89>P4KHIIRD0HY)\:K,-7(VX,X<QP?Q+[,PRG*1!4*
M(J5;BJ7/3DVJ()QRMHL;W4V2^W)LGI"O&*0=11Z+O\#'$ 1\P7@IH?K*!BRW
M8+PJAU]%EQT$1Z_HM8-9Z AR%D-4_&;)(&<;.9>N^:5>U\73Y5*,B691"#;#
M(]AK?@U@7'<V!6'O)L$]/K\!?G#_454ME@2@H#(Q@]&5^5A$/SG6_]Q17N,
M+'E@/L!JMGR/$#GDY5I@/$DM0%T-8ZO1-2T8^R]$DS/U _1\2E=3 %SA=S#F
M#)2\DW#GXN&$YJ+D!6Q)[P#'KO<.EM Z(?N@BOBAJF%5L7"$\&F>D7;+G$GX
MV /CQF><\Y!-'<\>F]$]9@$?9/HWE^2MW+%"[F%%G<YRM2)P-\B;<Y ]?/%;
M[98/#K.V%+J89R.:4PZ;LLF?V+"!6GDF;AG6 @"@C*_5:3V-&D&W@/1%<BW*
MM_6H!&L$C+L*&0IIC'B@I^TR19AGV^LBS!)%F&?;ZR+,N@AS&T68E3 D9T1<
MXO%+V=R1Q:3:- ]D!YG2R'+NKAC_64)0>S1_- =]F:=7E'2BDZ_=NCEF([--
M C!4^L S+X$)LIW(."3K=1V+DS7#5D,K68#^AL^>"#\K1;(PLT6W92RDI3+L
MU)+E_+216NFI!<($!%C7)/*:NJ(BQ%<W*@*E>ASUZAI:,!30-L8KN##O"2XY
ME+R];2#'R(A<3^6V*L)Z53'@("&;A+CN+SZZ,16PVMG= "AL/+HAOK::@X-1
M7&!37-#)2>O!<36$V.-*] 51![*>\M@Y_!,*7^4+(5K+):V,%9N81[-BKI(H
MM@)=M<)$Y-51^KGF4FX\QLE6P\$,K\CXJ9TS3L$5S\IQ575 [4P5_@9@7BI>
M%JF6Q[5UW:T'ZBUM)$OG)@X7KKY.!1/\3&&S8:*O*YI?8.W&YOGV[<Z1/@7D
MZ,J;(WKE$5<OL_7[SLOHUK@&[DM"W\SXZEIPD*0^>WELFU,XS_&*HB"[5>\X
M3?W--T&\(DSDE;53U2Q=]BDRKH'9)UR0U)&_GZ*F3M^OD$B#@Q1$U+%W(H-&
M-ZI6 W_%N?$0* =P4[(MVM#=_G467;?\=P*6"D$#5SNI5&L4K+WY-.*T(P%W
MA:BA[C"R\(D7VS\L_. &>@Z*J\!;\6_C3X"WT,,7)B0L#]<KTE!&R')4#5UO
M1=T0_LK;9_G\-OW4%?C+$([XC1>;%KFR!R4=YM>IBB,VS6U=FEMTAR!E'="E
MV%8BQP.>H0,*;@)[9R(?W. %;:BE5*2/25'*7_[D!+J_BKY5^2%LULF&*!HI
MTK)%>I69UX3F)35>Z8C2H/BEH1L!N3,NW4L/XU-RU(Z].MBMZ$RRC.#/ 8R
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MW 9HLE@WIC$C56U+-6=U40.NX';#=LL[#H6"&L]$+@T)WMRR3]/+4*\-5$J
M"F[6<<ZG[H)5,^OCP0L>1KL%<&%@AT/  >&AT3-.8*7 OS+S?"3VX6 A&]A
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M36N/)L..W56262ZEY*9FCC8)'\E_(&%N^ 8;1'FLNJ? 0)3JW)C!G5Y;M!"
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MR3A233%+@)B;"1$X*\P*I YY7-@52O_6/<'U@&G=*HQ?>4<)".YC=X2$-^G
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M8#X@!GN7P%=V@'>V,P7K)*_:X%\H!G$"5:_,=I'O^V4CJD5"=#X;<6K4-EI
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M;@T 4E2(!;7>A/(-W)%(UA%R\@LK2++J+N/$D?@A?;3$.?Y:@T60#X?V\_F
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M;6<TRUG8.6V/$GXY%%?&V#T>J$A9836PEH&8"%_9FMJM;,=N_6#0\?+G##R
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M3'A[SG*0FAE#^F:\1(MS7MW \94AVH5T9QCSQU6"ARB6OG#_KZX+J?;_#IB
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M/V"QP*=L/%5K1>B% LSRA4"!V:B((8X=2MO'<.I9)W\3![T<'83DD>HT-N_
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MMQ[5Z3WXZS5U#_[OFKK^:JO0F]4&18V$C/*P>;69G,=/O9]O6SS(/(:BDX:
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MGV/Y<R U<E@6R@GY8"RL-4&UA MP*D&^=+1%?^M!!!.4G-Y/-6WP!2<GG-\
MKTYXX8AX1GVLIR"%/6:X&:=@3E0<UN(GL#N/ &&,X]BUO&G>7^6'R] JQX8=
M#*<T>J;BBM)!)31H01FE5 ^FRL-Y2V,4G^M3N5"2[[$TDX./HO$SQX[UO*U%
M=(L6D15Y&@YZV!*VW,%W?^QZ07\^//SHJ7)R*YR$F1+M2LIH))3:P,@JU9]S
MD"G;;LU;74D.U&["3C7##*%-*FSVX\/M$M[B$A[G6(Z33/ $]&Q*9I19!ED:
MC<%>H\,7C]QQ49;%!6S*.;6L+G0:/J!/'6*5?SQ\PNT=;<84C"@G:DM76/T:
ML?=""5:FFD8!*DIP4?"8A@M+/M[5@2T4*"AOLR;"4B&RGL!N!\M8I6$U3( S
M>)0!M8ME751 :LT&V=;T6ZQ%$FH:>%$T8BA#!(<2&=-HTY]12H>2S=.,TZKR
M KY"OW&4B5V98!)3HNEP8U-6/ K)U4..0?-RZ!M8KT=N;C(KZE3F3A5'\1I-
M$N+,9>>'@:$NX;7C?_CGFR9!3;@D(80%!=EO<1!<HRAF?$8>V8+!355+#D0,
M)I1&Q0P/75T97D*PTL:),MLP)TIBT(:;XOFQU1EWF=#NR3;CL$'&X<DVX_!W
MR#C\&ZH"RWS00)]?HR_IO)E?O<!DZY7=ZDK^5Y,3,,"DE_J("ZR LD9_D7'D
M?&45JGL+T2U3D,(Q=H!7V%M*C.LB/B'%QE-@;*0<[H;1+J(RQ?'Q?X,0TA\J
MNMZI66FWEFYW 3&]0+<R>(LR^"Y-<I\7$L%B)? [[ID1*EE9!BHFCE9_W,S'
M)5J)0B5 $<BTK##^/&VJ*"/. 4)IG2?J$I5PL6">6PFX50G0F_+*I-=/MBMX
MBRL(EPP'1$#_&CQ(EZ7D,JMX<+#MA'#+*TD07$56+,G3;2GX_1J[7DU%R\G0
MDJ13>&8L/#M1SP>HT[X=LZ,:7N SMY JMIQD5K[1Y/(U2ZX0?2Z)P3.-&XQ'
M]5<="W"I][8QHA^FW(1)$HE2_*'YE(.$+,"8R'[/L!S>><16-F]1-C^J.B@0
M3G\\.C#A:%QY^RI3C+""=I>RW%HOP878&UDJY()'>P<[433"QPT'45U'^,5J
MJ Y%GCG8:4>3"4R@?L"A<3NDC*+:+/#.!@2M:Q$TR7*(44\.@[?P#SJA;S.\
M6SSH0A2-H^B.C7ZL8MTPA#RYH.R:Q%X+"<=.Y"[;#7$W-@3Z1#T@0,/>S^V0
M%?E#H+U9)<2Z*RBW R4_BZ$3T1="G%!]13ME8K<%&@[8^6+7&71IPM492]A4
M&-"'3Z]PUZ![TW'"J!?P["I)HV )UW! -5QTG_&2T5*+$JLOK'Z0_'2)'DR2
M?S7XM11.@?*0C68JPF 1)S.522$3)LJC66)_8L4L1E@^H_EB+1QA3XZ"TU,\
M*^F<RVBD\Y)0[E%!E;75>Q)>/6FDX< D9K@[9!4@&"N%XU6N(1*]Y*QH*&&D
M\T\XB?,$$7)IK"[E@8:$O6KJHL2!YI,,AM.^0B\EN&622>*7C$K&W5SZ35H9
M)IZ=G2^C8%((9DA)NFI'SI@?PTNORF<RI!?D=@_3LIC3 W6"BK&>JA\GYBQ9
M7U(YCOX]+%64<D:N870A]S:5EUHD*H(UY=X!Z\!5JB6D=%&8N.2+6/BZ'%&L
MJT?R153[A3Y4 3-[(VBK7)HQP. 6)=7B*39T?]VB^GB:I/0GI@LM"NW.["%T
M[4]X $' :(+?4:@&LX0B^BO.,JWGW!-=FL,3'[LZ\P6<+CG(2?ONE"F\TNW'
M[NT]X$DEW0QOI>"3X#1%?J8LCBVBS7:MF1OS3-2OJ\)S"&]/WZ];$_5TFZ'<
M($/Y=)NA_#MD*.]Y312#J'UI@78'J]A!P4=E+;VBPJ N&\P2P&FA^BF3LL5J
M?NL3T,A%G,KO_\1.VP&>F U2;E-Y-ERCD%!+Y+D@:+:ZE$MC](?&SB6$#S4U
M41WHX=#$<5<:U%Y,1R8987H088#D,[SC]CBX3?E3D2(/H?ME0J!;H..MKJ*$
M988#'<A96U_IJQ>9B*90%K$GVA0B&%(HG]K> !F*A?J-IEZQ:S;GQ403\%?-
M8I'1D[%>C3P:>#]RZ_'?'L\3K4XB8]Q*VRU*6P\GE%_B#+E43Q44_/&V*.?S
MX&3WD5R3:%(QVSWK,%K]P1SZ7*LF?R@Z)8D-M81Q*S:W*38-0JD.'C_N"HJF
MK+*+MC7CB6K[TJDTM;39(;%%5>S3TNTD1Z)J-;5^X7HN^ ]-CZ("/5A'SEQN
MJHK<:B!B50"W1@4')!V+3DM$#:*6$(4]M*T4WKH4/G[8)X7PS5>40HKO@3@M
MRH0"X)U3[]L(I=03LN;<2NB=&+N64"](T6Z7U3D(\4,Y_RKG+W4:*J:,WS ,
MF"U1,OB;[4+?B87>C!'%$*$\VA*AW,>QFY7'S3<<O.%.ALMK$24_W8FWX*-;
M74QJ\3(<4(^7*\=/:$?K UH!?(0T9.+MZ?IHN^RWO8>9$ /4-Q&<1%E7AW/R
M6KZFOM>*N%?28ITNK#UJ7+S@]_\\.0H.YS":.,HE^+H<#MI-WD<F15R9@7KS
MN&WL#/'"V-63E+6=+S+;'O9SJ1*XAUOD=:B<J)1BZC=#W%K*@Q_W?OQ1]V?O
MX?7QT3,ZK72WF^,N5U$^V^8H-\A1/MOF*/\..<I_0U5@G9-6SV]?VSRVDO"P
M9!.HL!N*ARYZ5(@8I):>6B@HM$\;5:V0JH[IQ* F'^H5#FHX_S@U,4ZRXH(/
M[E9;\QQM,SEL*IBZB&!$"T7VW8^HS6%B]?//$N8.ECGR-$4/U>3 N>A2QTR*
M+(M*M@[@RW0^3R:(F4*TZWF49H)VRB=;U_ZVA9Z@44MO:G]I2-&67FA=M0;0
M37CN-3)'&XO8/4K;O$1NOZPJ#%<9=BTFSCV.3LI_KQX@<G=S.%/#NS@BN9X,
M<2N7MRJ7XB8,!T?D)VR)QN[7V/5*"@$]^CK+KM<9P29<HN8PQ(.]W/5IA<#?
MG*F/!.^[7=J[L+2\0)[5U3T=3/$##OFS +X506SE2D"[]<V:IC1LK+0[)SSO
M1B'82'L?59/H7\%K*=?AL3M?_9P5XY7?G"18Y*$NX.?C?%'%K3 O*.[;'94G
M4QJM4BS.>F; 9BS@5;9ZZI:%606*0%>I2)$OUP$2^=J4.A)G=L)&MF[8X<,L
M=9-?[T!0=G];.$2X<+ E7XA)M^*LIVHAITG)R&:R_I-$B2"+$]W*"65.W938
MJ^.F[B]DZPVB=3M';<VDNS!V5VBG%-B=>9%-1_\; Z%( P/>6<IBI[JGJ3)@
M[J;35SGCZ*[UO]F*PRV*P^]1F3(1U"?43#T\O2OZ)/58UA'Z_6,NQ_72AR*_
M-];PJ"*<56KB7D[QWT,\_O!Q_H9D3I%W3;!9L<'C).BV3F0F@HY)QU5<0C1/
M'GQ2<9%KZNGOEW+_N^&@8]=Y.O_9#;"D\=5%@K1!Z,F?)V5DV@MX'J6;2Y!U
MJ#D^$\SEU$A:G\14JD??CU3$K.5WK+1-\4VZ!FJ$?)J@$B41]2HK"F1)F 7O
M]C[N!3MCC/<-!\[K8@<Q2H7]^/S1?A#MS>$Z;5.^QE($A%U11[O'S_<?!HN^
M*X21%6;^P^GK__T*1X7_\=^JE9M^I++;>8IO>'(#S]RZXP'SIK+#/52MV",O
M.=.]>F:ZU9^R]<H4?9SR.U2MCFFJ1VO$]9:Y63&I,I6-\S'-P:A'DEC=BX%:
MPU'5,2PN/$DD!;;2<1[OL<FO@7%%.0,M^E>D*A*E (7.U(37 =MN(%]LD\<Z
MA\JC$9YM&/V(EVE>$)<6YAJ"<3J1Y5DD0MSA72CJ <SO1K"]G<F(%1HBU[%7
MK)#S@E2*93K%XEMVU"QJ6?,(EW^N:FD*+@E*L(,AQ?@6"VP&0!U5#"VOJ:H=
M#D2[J%-#-6[0_3<P@"PD8^H%+;@1+9Z=<N6,=%05.0C6TNK&ZNFJ$/*!-4TD
MDYU\@6%73(#"NY[/1!7&[[8WW%H\=SE_^\,V?[M!_O:';?YVF[^]EZK 6+<J
MMN*S< TM2[8,NP>D9@NZD'O @4:(1\- ).UPH]H&\/A*OTRAX4,P@'5O*%]$
MB,\7-6YST-C=QJKT"W(8U6>5E;CJ(U<BQRT*5+,LTS -65BDX3D\/5@FF)I5
MP"LXZH\Q.@!7'*D.7EQ!)X80)M'P?M09CV)3+#&O*;FWGJMI>T+>_K8 :Y<0
M;'[P]HI6=:;QMF[O)B*M!'>[O-_> ")0/L>J'^*2[@7\.KW__!\_HC X@6J&
M<)#B^ A^BH8%[P6G*!()TZ5,A9<9=2$7UVL]-9&[L<-+3"O\H[?!D^^%KI+Z
M(7:(_H(=R\&RJ[N#=G'W2!<-6+T(65JKPAZ!'A5SNSUZPMU.2,<JZMJ<&B,J
MMARGVR'J;O AZ$D7)?+5<(MT*\KI-)5K]P;L."$./:-G A \%,*-5C3R:3&*
MJ:.K_0M[3X]&>\%1Q%X+NVKMPGD[>QXA/X-Q\/ZQO[>_?V YDQ3_Y1+8B5RF
M3Q(FS]M#[CS??/J2\</!(\$LM9:?D>E!&YB^38C=KF9YM)%F<?2+,+R32&Y7
M[YN//1IMM%AKEX^(O%Y'U1E+@.@9RT)%3$[&-A\&HT [F>HN.X,D32TC4%UQ
M,Z<:@?-$-P*HE#U=$IN:UCL[$28_\0/TR2S4HJTHS/64=X 3!S^(<C@G1B]>
MO0Q?/'CU4K>T JU5UHCEQR#A?T5Y@WBQ S@#%V6:X7_\%W9//J!W^!#7Q1AS
M:O#Q.($ES"U>4XZ &RIF8WRCA42:MQE7Y$!W+]MQ2ABHE2E,8/MHT!1T>'PF
M$_ A=N3&$FMUCPVU:'"(4\.G=I'6*-A)F<3&>V4G+(R1Z+!5ZC$<2#<IZ_!O
M-,*40*,FGFG?:$0Y9Q D/!MU.](@2V94Z&N@H)3<A@-CJS2^^=C'-Z,TAH/7
M41:K,B!6'%JA*%%IR[H6IUA^RUD@O'0<5:D86X^>[N\B3@S]UI#,,D4V#&KA
M(LE I3S:QR;(&3P++!J\EIL05Z'56Q=<];)1R23L4Y[D\;JM;?^>3-YDSFI/
M;D9.-)-94QJDU:,.!IQSOF*2Q%E42H%0MY-=R6WL%F6!?7W1IBH765,9/BK>
M.)XDO>PE4)@&5RV)#K5IX5=:Y=J+PJ\5<P-O_4KM.BM4'>UUT]JIW9$\[(PO
MBFOF#)68BNI@HZ=92JOPL1)PP#R6ZB)MUY_9I:0[Z8A0,.DV /_MQQY?3V6\
M@YTR'+Q-$E$3AP3M%JD,)8TL3)^4==&R@=$KZWBIK"1TU'.^B9 72+K:6'(N
M\"KZ%JT,L .B #50,$T2%9R;P]SIW(\<9:%CM6 =X$/+]@AD[R%'/O:T$<M&
M*%"90%:?JH:&V*.A=&&D_[U4ZW*NL+"K&16NG7>>U@(P_&F39=OM<I?S53]N
M\U4;Y*M^W.:KMOFJ>ZD*)M<[.3_41/GN4N_L!2=%D!4$U/-::WRXE,D\2IT@
M90BN6UJ?)67':,L%$F;JP]A(Y>@K8D;@[F +AR9WIBS5"TP12+65%&PIPGC]
M%]Z:>QU:0(Y+O<9P<"/OT3? 1;2TC':I/9-3F)CJ/Y/]@)]BS[IQ0T^C-(G=
M8#MR?N5<.TD4J-+F2.'+E'V./C9U,Q'KHSXSA/[(?,N,_GDG0N^#\@J->DWB
M>8'1ZO8E:<4 \3G8)RZ5I;(@3/\(JZ?)<*"Y>D8A3;C8,NW9&2-=R"1QNWV'
M?EE $;!%P9V3MC.I0MLBX4V.$]8>R[S(N;4%Q:;!N9RPHX020I!%G<&T11K%
M?,XEKSO:X@JJ-/],%/X-K:P@J%#R1XHQN/M*A6ZNU-L[4T/RMXV1_&/?9,C/
M'MY0_/OQFO@WJ^3?"PI%?**>IOR+(^X9'U661M0M#=AIY=X-UO>VGPMN0=@?
M+I$.*'D1G/.CN9TJAFDODG/JSN!NGA4MO3!'9.M1?_P6_+#0SI"!ZIM.TW+.
MT5P8A0[0_G+U'%F7+@X!Q%%6<YQ$RJFB"88-$HQWT%:%5T;J7M,[EO:9-)B=
MP?#ROH:TN #JYL10MKZT!W&U40/34*9_$8-P@-FNFL\'."F8%H9U<!FQBF"J
M ,N[M31*^TS 6>-^%'221('5B1.#XG!H3 ED:>?4GHQ45]ZZ"-U3>*6>\4H8
MHW!Y.E#S1]@7+N,U,BSM,G;I/X/M@VJG_ AA,:AQP2'FD[ VZQ9$1./(DJD:
M 3O"$U)G$9U)='._>OHG(CV$L.F\!:)<01>3A8S848YBZ9HH;XRK78]WHTKW
MJRNN>ZYKGVRD:UN=:?>"WVB?P.)9C:1#W%3@\39*3B]24C>[S<)C&84Z&(L(
M^+PF(@&4&?WG<+!CYUO\W7$%GKU)IDRE0BC%0MO=C$$UD2-H/46 0PTA<RNS
M%,6(!>UR\V.@%#& 3')/824./;-Q9!E4; ^;8B\)-R>)TZ ;C:Q)-(]F"G"M
M;%,.OJF;<%>?M8H4[:[$#U/023#<AQTCDI1N)Q=%9J5,@8W2\)EAH2H*,-/O
MLY?UO=.\:N"PB]-$F%G0-9!0FI"FT4(P<IX-4UST4M^=26#T6[0QA9:PP+,)
ML6Y?:UCLY7+*S;91AQ2.9'6&$B9#8M5[4339A(.8G S%UVO4Y%<X%V0CRV_4
M56I)J4&:\D H@#@<G'IG:XXQ5 6>R:EQK6Y6RBV<K#V*L5WJ(TJ.TN,GF+1!
M#E ^R)ST!<4S!852L_D44M&$1<"S5=9?6UEO'L,\V-\&,3<(8A[L;Z.8=RZ*
MN=WZJ^VTIY?&A+EMR__=]?2]P8*994,L5AU\6"@7U>!4>[&F'72'P0)3]A1-
M DKRHRW6[:A#GY ]BB4/[.E[:QXX#UOHH5F5&A+F#=G[(T.H@R!NX]UW+"0K
MY7"QW9B*<O:06D\8H6P^2$:C5CTDV=HJ.>M V%0_U'XS6)4;JL5 )#'856U,
MGO1&B,VBX4\YYJ2>W.'2M6L[S"^5Y:;K.A37",4M#\&E_S(<'%(8P?&+WFN#
MS]WQ&LS+PN*[3%Z"F0V7?K2W#\K,EK6%15G[2Q7[N<"E<8Q-:P*BFLE\>^_7
MA7/S#2WH7_]=-4Z2T_2JN)SDP+H\58X#+RV^'5\X(? $LC,+G-UYC0E# QR>
M9MD1&G\#DK&WF$R#\S0*$C+:Z>'>E>E6S.(N47"G-B"]!9YRE_]XBC'+-B8R
MM1DMT;/QCB/L; ,+VS%.[%=7F8Y-7R>M%*K+%'V9[@-P&QC5YUW=H(EO2TYY
M1X MNNQ.]B&9P'_BI;,FPK*9A$OF)5D$AB*.U'S'R+"HE,)QG5;P/YYVL?7T
MO1?'+X,7#XY?HJ,66[ \KG'.:RK3<#0:3LN*O8GXF;+(3-=GD'0AS(:S)YU2
M:3:U<#Y+,"X,#PU@@Q0P@Z>%3SVMVI\(<!6A=0HWU.M)GV.DL1%5#V:DCC;L
M5".L=\>FRMQHV:UP:F]=CT@T.7FF^&0Y5%8H(?THY9TBQ@>T>578FBE5^SRF
MZ@C#V:KRD"Q[[7=Q7\3VVGU:"#MH+#!]:5!1+:R=.C9)$^TIZ)UG5O30^?QT
M6<PY+89[IC<80=WO B?52BA/N"B32%1K:9D_?9OINF_XWXYM8FK(K..,>2KZ
M2)#%B*%0YHM7+_^QO_?T(>+WG=JB:((O3Q$AR:'M])T^UDC^EK5$7]]G=\,'
M^YW@P3XY]>H19-R#RE<3 3_Z[B6.\TUK$,\H[+.()FB5&@].317>E9S^S@\?
M_KCVAU>%LNK)=1_L7=BO,  0W%\3S&ZF<<61C=OZ'QXIM_G\ODA!.PIT,]OW
MQ_W-MN_NP0]W[V!XNN'@KZ5[TCU4\5<\'#K_I/)C[B/5-E_%#*%D7DL(T"8E
M5+8@JBB]$I59RBX95@'4%T6P\W#DXL+1P-A)\5O'A;/9B"O".I5I9;GF6#Z"
MSGQ=<\/?X"-7(=C)=RIA'0D= Z4@.G5>K?)6\N[[FFB-A$"VFT\1FY"RV3$R
MK*E4DO)30M?-)!M1K,J=P_:K=^>;"\T4,?IP0*"#EM?JQV:TJ9&FB,LGTBI,
M7'$.*DMF7.*'[JXLC?X>/0 ;*%>?49M' =U'2\ZE>=H/==DE1IS1VWDU:IG2
M\(L+3,-ISDK$,/3W(1"_AK.JA)[O3YJR>=.[8CT5+OI=6LOH(96"Q3"95(,.
M)/ZLLLCQK*4^F0Q(HR*!9%%4:5V @)V6#14RS1>4ST4$I/2TKS"_R,QE<0;;
MB L-S5LLDA)=2=HABK],LY+M!8=5T%0:PA2Z%=P]6Z>'<$)=7YGKN> G1 JN
M$HLGQ+GH[E[:X:%NIF3&K_M?P*Z>1S03#I.?KX-4F\H,.SRQM^HP2V,)E=K
MJL.5QUN^>2N3+:;[Z;Y<<NR;I!8/MJG%35*+!]O4XIU++5YA2ZC!WB^S$>S&
MZ]N,'%QX"T=T4W(O=#&@N@<K&XK'4TU813$V)V#:CB93)*U[0JNB0X?^"_'=
M:/Y1;8"W$:+87/*%Q]RSP6%^;!AW%$"3Q<7/\"DU'+2P_#J!Q@@W04LA8I-
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M=@Y& DV9S<IDAO.\MI"I$R;J6VO-,>DK5)DW69TR,](861 >RM2Q]T'2Q[.
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M!+T1BC:B'JVZ/-(L5BDB3["8NJ;\0$VO4=*#.&/Y.4D6ULG+)&O# ;$8&M)
MQLN(]=MC?"IW#=02^>F+@N/]&N_00O+T9:0C;(KBZ\'1TPTEY*145"E#1"$G
M0BZP(&=M@?GX!1_RPIYH)^7%..5V![,$&S]J4]*P+3*0I0J<"@QMSNVH!#!_
M;3&J>08]:E-Y,0A#^:I^M\D'O)<P0"L'SK8!-\(3C).G<-U3%4+<;2)PX+O6
MT6=NV,K]'\@()'M0%Y56TC?<JE!!T16?YMDH6%$>4_<SFW;JQ9G0V2,4%NG
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M&UW;B^<KG[0G9&2JEC7=8)W=W 4\C"SQQY;@(RNZ]9S@7@MJ?"C&K*HKIG"
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MMTT^B8B['\X@*^5];9R4AX<I!'L;2Z>S)5<_J[_(7"WRA'P3(4(22C SH$J
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MP:L/;_Y)^_67TU_?O?R_4$L#!!0    ( ,!:WE2[8V 6.4H  /G< 0 )
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M&C7%E3AT4X6?8V4,JY@6#'<,GPG'&-^"11V77F@*$^EH-^IHDYO-I"&33TR
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MEGI2'I(O R%-TY$!43?3RR)IS3KOUM7@6+$X>#JTRQNLXDD[3&6]2L2PI)Z
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MU6@W+#2/]C\<_I-,MS>G[]Z^^O]02P,$%     @ P%K>5&"#^HB."P  TT
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M9<@(<F/M,Q<\",6*9KM%_%%16!?-'TB5"8OG$0LREC%#KX>#I:3D6RJ%Z\;
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MC8JQBKI^U@4PDQA@. *Q8R/I%.DDX?-O-C;U0]@!,E+GPWM0ABG!'&IE <S
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M K22SXB55:#?9"6HJ,7V^^7U3=?BD]BL-XF_5C@C8LM_ 5!+ P04    " #
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M.RXU8'>40+X]5+X5WAK&7!X[#W3*7']=5]S)EKJ-X7'!4P0(_@1SI BZ18K
ME1 9X0]T+E4-^%TED/<;3-Y5WI P_YT19:CB*PCI S$0]EM,V!Z'2+P?%1&:
M.3X0X(=J(/%3U L/CT<DY*,9Y=PE<$2 ]O(J/1#['YC8_3Y? ?B;9W=^MZ<6
M./NM(D#\?[X6_ =ND2)P3Q63B3VE*P#[ S&0^ADF=8]#5-XW(H'2WDC!^0\^
M[#U[2*@'3,>$%ST:V&TZC+M"#D6.DG/6VD3%_B\E"@Q]2PQ%CI*&UEAL&'@_
M4VJG,\%1Q:^&(D=)0.M,-LS\1AAF5NZ._Y<L'?^\<;K+^E %98R2=/I,H; M
M[S0(XQYDA/CN*Z&,47+-D#D4SGWK1Q$^% E=?J*K$.@#*90T2HX9M(>"^EZQ
ME*C5B,7U@\:A%@H;);,,&T2A_4B6P\2Z8A-6/ JLA^XM F6/DE:"[**$8"AB
MJ>9RZW9Q7V;V>%SU91(<TFL*0L.!DF^^P#I*4*Z2Q.+2ZS^W3-!N*!25<O S
M(KP !&R^$NR]EV'OP;&CY*&U-E\)]I.783^!8T?)16MM8F+OVX]WZE$N/$^@
MO6(H<I1<M,8B)O#\3'.G[I5\9L6,J#KJ!R6@Z!%3U+!9U!V^.,E#]O92">6-
MF*Y6F\/D?"^U(?P_-J^[DJS60YDC)JXAHTW?8"SB[FY:^*82[4F@?%%RU4H[
M32-U$5:4^'??7044*$H"6F6F89ZWTCW[F$D1O!][J()R1<DD?:::'GC=/&+M
M/?2WO@;/8$,95O=M-(SQNV+&]J OTS03ZWLTGJ=B'BD4+TKZ%[37,.J1Y"QF
MAHGI9WN%J!CAU9RK=%#(*,F>WUC#A.\5=9&F]K([G\?E%AJHN\G$-_*&]%#B
M*+E>O5%<\D.M,ZI>RK^B%#0**&D?U'33XPR-,SOLK;J]\:-;,>,990Y44-8H
M*9_/5,-LO\A'1=Q*O=$J'4ON7QY2*8021DGP M8:AKS3CVJ\>Q(H6)3,KM(.
MTIAPLXQG1$RI?_9"M1(*&"73"YE#&WNGH+%W^L*Q%R7C\YE"8EO,#;='U-V8
MLRGQKR0+%@"OL\$D'K#:]/J]?,F/6\.MTKP? _NA&KM'"@6.LT0R9*]IU%G"
M#$V*+@V8("*V*=5F79LG.Z\O!0T SAI*H&F4V_O?*>>?A%R($25:"IH4E_JA
M._S>(M H(#Y#K+&+$H)ODF>6DLHG@BK/,>"10I$C/COTV,.9>UE,:MZ<>XJ7
M=82(^TI P2,^1 R;19J?9JCK,WNF'X@AZQZ&^/M*0/DC/E ,FT6;/Z_Z]L0S
ME>%GYGM"*&W$J;"5UE @CU+"^76FF: Z.+;L":&0$>>\5EI#@7R34C6U@]I'
M)1=FME[;&8+M*0"%CCBS-6@5!_[RYSKR8OU;D'R%&OQV D3L7I-8K]V(8S>1
MHCB3BX0H#_60'LH==6&EWVC#Y._,C*KMZZ>\,T.;MX4F/=27@D8!)5V%FL8Y
MMVZMY ^>6G=T4-Z(B6F5,9PU4]F8LWC )0E>E^_(H'P1L] *6RAXKXEX4MG<
MQ*M[)6-*W>,3O3G:  D1L )H2!#STQ>AP+E=(-/4+2:2\=-H9DWKN\SD[RZU
M_0O>- B6@X8&<Q$GP#C259#^N="+)M>K!SJARDU3>*1+<VT;>@I?% &*0^.#
M^D8A,(:*,%UT#GS=V@WN[;3%-^Z7>P.KW?(_4$L#!!0    ( ,!:WE1<!B4
M(QP  &JE   +    =6%V<U\X:RYH=&WM/6ESVLBVWZGR?^C'G4PY=5F$6&P<
MQ[<PQ@Z)MP$[3O+%):0&.A82T<*27__.Z6X)"81-;'"<2>;>F02IU7WZ[%M+
M^_^;#$PRHH[+;.MMNI!3TH1:NFTPJ_<V[7O=[&[Z?P=;J?V^!^-@K.6^3?<]
M;[B7SX_'X]RXF+.=7KY0K5;S$QR3%H/V)HGC5$4IY#^=G;;U/AUH66:YGF;I
M-'S(9-;=\OGQ;CBTXY@L-A2O!(L4\PM3PUUC]D!T<"4O;L:&>HE#RV*H%PQE
MKEU2"SOWP2%&A ],EHTM(,RP0_KIL'4Z&^XECY\-S7N.9KE=VQEH'M 09RIG
M%36K5B*39%VJQR:"W[F>/7IPGMULL1#,LT"<^$[Q=D=S0XP;= [=P9IP YY0
MU6"@0[M+IZWDX6XPT'>S/4T;AH.[FMOA ^6-V*QPS;%-ZB:.YG=BPW7;MSQG
MF@RQO!E[P'6\Q:GA8FS0=>UC.QRE]:C6,VE.MP=\D%(!&G'9HIH!?Q+\9]]C
MGDD/]O/B3[@[H)Y&<(HL_>:ST=MTW;8\:GG9J^D0D*V+7V_3'IUX>2&">7PN
M+Z?=_[]LEAPS:AI[I$V]-^1<&] ],C$F;TCSB/_E5E$/;Z_;K]2CDUKM$OY
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M^IB@E(2Y2QNV8'YAP^5N:*?Z_?1;I3*JE2OKYH/8ZNF#RHZ*9<Q?0QBS76W
MS.G>:DGI;;EC;J)G@=[?_]E5"SMO7'+I %^PH6:2QH3JOL=&E%QTP2C1#%IT
MT\=PBP"F"*+J]1PFGFB2-IZE2 I^GY* :$A61CU2<ZBVG'E[I_JX=FV-1Q_6
M85RBZX$G45&5UZOJK4#Z3FWP;2[[MG5OP#&HM.YJ?L/:+3Q>5\W GE\S?5!4
MR]E*L5)<)2_RG F1!,FXHB9]M/ -<=-;*;'MJ"0A%1-%Z7EX_VG*9 60\Q9:
M*O.1D'_U7?"(IXFNZJ-AK_>I?K>5PJ2[-@2;.708QC,=>T(ZU+3'A(F,_#%
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M"%.5QT<<5XZ&JXMMM:>#CFUNN_>7N*)MZ@N[EC?E!I?=?JC2^]-8 )M9XAQ
M X4!T?.XS^"*",>I0XVG6;8Y?#X69?*^P,=2+GQ.)"ZKK,EH:EI0.US4DFV?
M^OGXTV'7_:*^6T?.<W[-] $:/-N2#._9^ET&T.&0D6;ZE/REY)0"&>*9*CR?
M\ABS]T1RO@2"!6D'J1R$6ECB4M^4+IDU_#KHKH-:L073!WB^]S<G0<"_@=^R
MO$FQ3SNEC[1TJ3R!$O,%0E1^B[7!))A =7YN-Y:5$VK\IV8]0V?"@P[GVI/5
M/PW"IF6@ PP&JS,E.N:G<:T[,%.4M]C,Y8Z92V =<)\1G![I.?;8ZZ,C/<1T
MLN82@W;!QS (LV0N3"DG])G/VLN+H0.-N-IYP]-B2OGU5LIVI .N=K+JBKWJ
M\Y.A3XZ/O\Z]9!JLGTN> $PC3MNM5$#<93D\4<X.'COA3]7%,\E*QCBYO*F?
MU=\U:X]O)5PE,+T'L)5CTI=8UGA)K-OL8B%IF4+(@!H0ZH7$M0M;*$KU07=0
MD^H>Z [+YN&W[U(^"@"6I2]\T0OC-2AQDAO9@*]E3GG\,6:P-O*J!?#"+8>.
MF L/@DK2+!TSIIK.7XF"H.)K=@S-,5Q1],(%AHNG9B#^W];"HS)1G9,C(0^]
M7/J\? Z:ARURP!B/%K^!<=]\3-D G.*<,7?4%H\\QT\U1TX]1YM;*@G-+:*F
MNWAT.=Z5&)SR7EC=H=I=MD.!%0'$(0=Y RM&SUTG'[E>(RUQ\9?,(S]%'<>/
MQRNR@:?IT<%6JH 17P//"&"AWB8:">I'Y @=(L:[F6H]A_+,X[I/VZQY3]$S
MBR\6R'UV,',&MU*7O@.JV8TAF:W]6-/Z]Q#@>OVPKM+/HN3*S%KGIBZLK53L
MN&$&"-+ =VN1FI"']M0%D7&Q$2E'MM&H8I^3JKR1KAG_57CSFO#6(1Y)<(&*
M>/Z+M(Y-%%X-I@H= X(OUV.>CX8=0&'6B+H>^ G1IYOR8@B'2-C)P&<"_@IW
M'C"ST[=-+ E(WT#"GR/1L[=X [8!^[6[HO$GA"[#;Q[:X(+@%$?, 8_#=MRY
M^6+ \=$A9)KO]6T'L&_P!US-Y(?H"DI&410BWTL%%S3TA\PIQ&8N\ (H)F,K
MY0(UQ-TA?_D08MH5F2P19_';QZ3\"@"Q>!(2JP27X6">]HH!%SX38R>3>H"
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MV*ZC  "PG , "@              @ $     97@Q,"TQ+FAT;5!+ 0(4 Q0
M   ( ,!:WE3-DO'I,@X  "I8   *              "  =:C  !E>#$P7S(N
M:'1M4$L! A0#%     @ P%K>5,XB[ 2090  ,)$"  D              ( !
M,+(  &5X,RTQ+FAT;5!+ 0(4 Q0    ( ,!:WE2[8V 6.4H  /G< 0 )
M          "  ><7 0!E>#1?,2YH=&U02P$"% ,4    " # 6MY48(/ZB(X+
M  #30   "0              @ %'8@$ 97@U+3$N:'1M4$L! A0#%     @
MP%K>5+/:9V)C#    S    H              ( !_&T! &5X.3E?,2YH=&U0
M2P$"% ,4    " # 6MY4I)^%P!4,  #[+   "@              @ &'>@$
M97@Y.5\R+FAT;5!+ 0(4 Q0    ( ,!:WE0"A=[3*P,  *@+   1
M      "  <2& 0!U879S+3(P,C(P-C(V+GAS9%!+ 0(4 Q0    ( ,!:WE1R
ME.3>_@H  ("&   5              "  1Z* 0!U879S+3(P,C(P-C(V7VQA
M8BYX;6Q02P$"% ,4    " # 6MY4%W[42%4'  #35P  %0
M@ %/E0$ =6%V<RTR,#(R,#8R-E]P<F4N>&UL4$L! A0#%     @ P%K>5%P&
M)0 C'   :J4   L              ( !UYP! '5A=G-?.&LN:'1M4$L%!@
0   +  L @P(  ".Y 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
